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ABSTRACT 
The health and development of a nation are linked . Health research is a vital element helps 
bring about improved health and has the potential to serve as an impetus for equitable 
development. Generally it is necessary to prioritise needs in order to optimise the use of 
scarce resources for development 
The overall aim of this thesis is an analysis of the setting of health research priorities, with 
specific reference to South Africa . Other objectives include describing the technical 
approaches used for priority setting and developing a suitable framework for analysing and 
classifying health research. Two other objectives concern measurement for priority setting : 
Specifically, how burden of disease quantification fits into the process of priority setting and 
a thorough critique of the Disability Adjusted Life Expectancy (DALY) . Another objective 
was to examine priority setting and Essential National Health Research (ENHR) in the 
South African context. A further important objective is the development of a framework for 
guiding the analysis of health research priorities. This framework is part of model for health 
research priority setting that incorporates ENHR strategy and burden of disease 
methodology. 
The methods used ranged from an extensive literature review to statistical analysis. The 
literature review included grey literature and draws on multiple disciplines such as 
economics, public health policy and economics. 
At the global level there is gross mis-allocation of research funding. Less than 10% of 
global health research spending is devoted to 90% of the global burden disease. In 
response to this distortion, the global initiative to promote Essential National Health 
Research (ENHR) in developing countries calls for the setting of national health research 
priorities. 
Prioritisation can be examined from a health problem, a target group, a broad intervention 
or a systems perspective. These approaches, however, merely generate lists of health 
(i) 
research needs and do not prioritise them . The literature suggests various criteria that can 
be used for ranking which include equity, efficiency and sustainability. These criteria 
represent the values held by the decision makers in a multi-level process. Increasingly, 
these criteria are being made explicit. 
The framework that is provided for the classification and analysis of health research is 
invaluable for the prioritisation process. It serves as a basis for an audit of ongoing health 
research and to help specify priorities for future research. 
The Ad Hoc Committee of the World Health Organisation was formed to address priorities 
for health research and development. The burden of disease was analysed in order to 
assess research needs. The Ad Hoc Committee recently used both a health problem 
framework and a health systems approach in the review of global research priorities for 
developing countries. When applying the health problem approach to setting priorities, 
chosen criteria were combined in a systematic, stepwise manner, thereby making the 
prioritisation process more transparent, with explicit utilisation of information. A systematic 
consultation and review process was used to prioritise health policy and health systems 
research. The criteria for ranking were listed but the weighting of these criteria was not 
explicit. 
A fundamental part of the process of prioritisation involves the choice of the measures to 
be used to aid decisions on what health research should receive priority ranking. Summary 
measures of health have not been comprehensively documented. Consequently, a highly 
relevant contribution for health research prioritisation is the provision of a synopsis of 
summary health measures and the applicability of these measures for priority setting. 
These composite measures of mortality and non-fatal health outcomes provide a 
comprehensive reflection the health status of a population. 
The focus in this regard will be to explore the role of the Disability-Adjusted Life Year 
(DALY) and other associated measures of the burden of disease in prioritising for health 
(ii) 
research and development. A detailed critique of the DALY and an examination of the 
DALY compared with mortality as measures of the burden of disease is presented . The 
DALE and Life Expectancy are also compared in order to examine the relevance of 
including non-fatal outcome measures, such as disability, in order to guide the choice of 
appropriate health research . There is a high correlation between Life Expectancy and the 
DALE. This indicates that the measure of life expectancy is adequate for describing health 
status. However, when looking at the burden or health gap, disability is an important 
component that must be included in order to determine priority health research . 
There is a detailed critique of the DALY in terms of the values underlying the measure and 
the implications of these values for priority setting . The extensive debate over technical and 
conceptual issues concerning the DALY is used for an applied critique of the DALY and 
woman's health. In a separate analysis it is shown that the DALY measure does not 
differentiate the needs of the poor. It is suggested that the DALY can be used to mitigate 
inequality in health by stratifying data. 
An additional important contribution from the thesis is the analysis of the South African 
situation concerning health research priority setting . South Africa as a fledgling democracy 
in Africa provides a unique set of circumstances for ascertaining how equity and social 
justice will be incorporated into all spheres of development. 
Until recently there was no national process of prioritisation for health research in South 
Africa. South Africa is developing an Essential National Health Research Program and a 
Prioritisation Congress involving all the stakeholders was held in 1996. Influenced by the 
approach of the Ad Hoc Committee, the congress rapidly assessed the priorities using 
both a health problem and a health systems approach. The health challenges were 
identified on the basis of the burden of disease as well as the perceptions of the 
stakeholders. These are similar to those identified by the Ad Hoc Committee for developing 
countries. A preliminary list of health research priorities was generated which will serve to 
(iii) 
guide health research prioritisation in South Africa . However, substantive analysis and 
consultation is necessary to distill a specific list of research priorities. 
The thesis provides important recommendations for the process of setting health research 
priorities in South Africa . 
There is a need for an urgent and detailed audit of both public and private health research 
in the country. The audit must include information on both expenditure and a breakdown 
on the type of research currently being carried out. 
Future analysis of health research priorities for South Africa should follow the framework 
of the Ad Hoc Committee. This framework includes the 5 step approach to identify priority 
research for health problems and the 3 steps of the health systems approach. It is part of 
a developing, indigenous model that incorporates burden of disease methodology and 
ENHR. 
It is recommended that a national burden of disease exercise, using a composite measure 
such as the DALY, be undertaken in South Africa. However, in order to meet the criteria 
of equity and social justice for priority setting the burden needs to be estimated at sub-
population level. 
As far as ENHR is concerned, the prioritisation process is unlikely to achieve a meaningful 
reform of the health research agenda unless accompanied by the implementation of the 
other elements of ENHR. The South African ENHR Committee should serve to coordinate 
the elements of ENHR. 
(iv) 
List of Tables 
CHAPTER TWO 
Table 1: Different levels of health research priority setting . . . . . . . . . . . . . . . . . . . 32 
Table 2: Types of health research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 
CHAPTER THREE 
Table 3: Sub-Saharan African diseases and injuries which have either YLDs or YLLs 
less than 1000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 
CHAPTER FOUR 
Table 4: Cause and Age Structure of Death among the Global Poorest and Richest 
2001o . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 
CHAPTER FIVE 
Table 5: Top ten health problems identified by the 1996 Congress . . . . . . . . . . . . . 96 
Table 6: Summary of major health challenges identified by WHO Ad Hoc 
Table 7: 
Table 8: 
Table 9: 
Committee on health research relating to future intervention . . . . . . . . . . . 98 
Major health challenges identified at the South African ENHR 
Congress 1996 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99 
Foresight priorities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103 
Health Systems Trust priorities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105 
CHAPTER SIX 
Table 10: Recommendations for setting priorities in South Africa . . . . . . . . . . . . . . . 114 
(v) 
List of Figures 
CHAPTER ONE 
Figure 1: Relationships among the Demographic, Epidemiolog ic and Health Transition 13 
Figure 2 : Model of health system reform . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 
Figure 3: Framework for Priority Setting using the ENHR Strategy . . . . . . . . . . . . . . . . 19 
CHAPTER TWO 
Figure 4: The factors that impact on health and guide the choice of appropriate 
Figure 5: 
Figure 6: 
Figure 7: 
intervention decisions on evolving health problems . . . . . . . . . . . . . . . . . . . . 28 
Diagrammatic representation of planning . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 
Framework for analysis and classification of health research . . . . . . . . . . . . 37 
Analysing the burden of tuberculosis to assess research needs . . . . . . . . . . 42 
CHAPTER THREE 
Figure 8: The relationship between health status, determinants and interventions 45 
Figure 9: Age-weight function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53 
Figure 10: Graph of disability adjusted life expectancy against life expectancy: 
Males . ....... . . .. . .... .. .. .. . . .. ..... . ..... . . . . . .. . . . ....... 57 
Figure 11 : Graph of disability adjusted life expectancy against life expectancy: 
Females ..... . ............ . .... . .. . . .. . . ............ . . ....... 58 
Figure 12: Graph of years lived with disability against years of life lost: 
All Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62 
Figure 13: Graph of years lived with disability against years of life lost: 
Communicable Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62 
Figure 14: Graph of years lived with disability against years of life lost: 
Non-Communicable Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63 
Figure 15: Graph of years lived with disability against years of life lost: 
lnJunes ... . .. . . . .... .. .. .. .. ...... . ... . ........ . .. . . .. ... .... 63 
(vi) 
TITLE PAGE 
DECLARATION 
ACKNOWLEDGEMENTS 
TABLE OF CONTENTS 
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (i) 
LIST OF TABLES . ................ ... .... .. . .... . ..... . .. . . .... ... .. . (v) 
LIST OF FIGURES ...... . .. .. ........ . ... .. .. ... .. . . . ...... . .. .... . .. (vi) 
CHAPTER 1 
SETTING THE CONTEXT FOR HEAL TH RESEARCH 
1.1 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
1.1 .1 POLICY .. .. . .. . .. ..... ............ . . ... . . ....... . .. . . ... ... 4 
1.2. HEAL TH AND DEVELOPMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 
1.2.1 CHANGING VIEWS ON DEVELOPMENT . . . . . . . . . . . . . . . . . . . . . . . . . 7 
1.2.2 EQUITY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 
1.2.3 HEAL TH AND DEVELOPMENT IN SOUTH AFRICA . . . . . . . . . . . . . . . . 10 
1.2.4 POVERTY AND INEQUALITY IN SOUTH AFRICA . . . . . . . . . . . . . . . . . 11 
1.2.5 A MODEL OF HEAL TH CHANGE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 
1.3. HEALTH RESEARCH AND HEALTH SYSTEM REFORM . .. .... . ...... .. 15 
1.3.1 ESSENTIAL NATIONAL HEALTH RESEARCH .. . ................. 17 
1.4 PRIORITISATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 
1.5 OBJECTIVES AND METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 
1.5.1 OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 
1.5.2 METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 
1.5.2.1 Method for objective 1: Approaches to setting priorities .. . .... 22 
1.5.2.2 Method for objective 2: Health outcome measures .. . ... .. .. . 22 
1.5.2.3 Method for objective 3: DALY critique .... . . .. ... .. .. ...... 22 
1.5.2.4 Method for objective 4: ENHR in SA . .......... ... .. ...... 23 
1.5.2.5 Method for objective 5: Synthesis of an operational framework for 
health research prioritisation in SA . . . . . . . . . . . . . . . . . . . . . . . 23 
1.6. CHAPTER OUTLINES ..... . . . .. . . . . ........................... .. . 24 
CHAPTER 2 
THE APPROACHES TO SETTING HEAL TH RESEARCH PRIORITIES 
2.1 SETTING HEAL TH RESEARCH PRIORITIES ...................... ... .. 28 
2.1 .1 METHODS FOR SETTING PRIORITIES . . . . . . . . . . . . . . . . . . . . . . . . . 30 
2.1.2 LEVELS OF PRIORITY SETTING . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 
2.1.3 CLASSIFICATION OF HEAL TH RESEARCH ....... . .. .... ... ..... 32 
2. 1.4 ANALYTICAL FRAMEWORKS .. .......... ... .... ... . .. .. ...... 34 
2.1.5 FRAMEWORK FOR ANALYSIS AND CLASSIFICATION ....... .. .. . 36 
2.1.6 CRITERIA FOR RANKING .. . ................................. 38 
2.1.7 COMBINING CRITERIA ................ . .... . . ... ... . . .... ... 39 
2.1.8 STEPS USED BY THE AD HOC COMMITTEE FOR PRIORITISATION . 40 
2.1.8.1 Health problem approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 
2.1.8.2 Health systems approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 
2.2 CONCLUSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 
CHAPTER3 
MEASURING HEAL TH OUTCOMES 
3.1 HEALTH STATUS . ........ . . ..... . .. . ... ..... . ..... ... ...... . .... 45 
3.2 MEASUREMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 
3.2.1 MEASURES OF MORTALITY . . . ..... .. .......... . . . .. . ... . . . . 48 
3.2 .2 MEASURES OF MORBIDITY AND NON-FATAL OUTCOMES .. ... ... 49 
3.3 SUMMARY MEASURES COMBINING MORTALITY AND NON-FATAL 
OUTCOMES . ... .. ... ..... . ... . . . .. .. ... . . .. . .. .. . . . . . .... . . . .. . 51 
3.3.1 QAL Y: QUALITY ADJUSTED LIFE YEAR .. . .. . . . . .... . ... .. .... 51 
3.3.2 DALY: DISABILITY ADJUSTED LIFE YEAR ... .. . . . .... . . . .. . .... 52 
3.3.3 Heal Y: HEAL THY LIFE YEARS . . . ..... . .. .. . . .. ... . . ... ... ... 54 
3.3.4 DFLE: DISABILITY FREE LIFE EXPECTANCY ... .. . . ............ 54 
3.3.5 DALE: DISABILITY ADJUSTED LIFE EXPECTANCY . ..... . . ...... 54 
3.4 COMPARISONS OF COMPOSITE MEASURES . .. . .. . . ........... .. ... 55 
3.4.1 THE QAL Y AND DALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 
3.4.2 Heal Y AND THE DALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 
3.4.3 DALY AND DALE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 
3.4.4 DFLE AND DALE .... . .... . .... . .. . . . .. . .. . .. .. ... . .. . ... . .. 56 
3.5 COMPARISON OF DALE VERSUS LIFE EXPECTANCY .... .. . .... . . .. . . 56 
3.6 COMPARISON OF DALY VERSUS MORTALITY . . .. . . .. . ..... . ... ... . .. 59 
3.6.1 DATA . . . ..... . .. . ... . .. . .. . .... . .. .. . .. ... .. . ....... .. ... 59 
3.6.2 METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 
3.6.3 RESULTS . . . . .. .. . .... . .... . .... . ... . . .. .. . .... . . . ....... 64 
3. 7 CONCLUSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64 
CHAPTER4 
THE DALY AND SETTING PRIORITIES FOR HEAL TH RESEARCH 
4.1 THE DALY AS A MEASURE FOR SETTING PRIORITIES ................ 66 
4.2 TECHNICAL ISSUES WITH THE DALY .. . .. ..... . .... . .... ... .... . ... 66 
4.2.1 POOR QUALITY DATA . .. .. . .. . .... .. ... ...... . ... . ....... .. 66 
4.2.2 INCIDENCE VERSUS PREVALENCE .. . ....... . .. .... .. ........ 67 
4.2.3 PROBLEMS WITH COMPOSITE MEASURES . . .. .. .... . ...... .. . 68 
4.2.4 VALIDATION ..... . ..... .. . . ... .... .... .... . .. . ..... . ..... . 68 
4.3 CONCEPTUAL ISSUES WITH THE DALY ........ . .. .... . . . ....... .... 69 
4.3.1 THE DALY AS A UNIT OF MEASUREMENT: VALUES .. .. .. . . . ... .. 69 
4.3.2 SOCIAL VALUES . . .. . .... ......... . .... . ... ....... . . . .. 70 
4.3.2.1 Age-weighting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70 
4.3.2.2 Discounting . . .. ... . . . .. ........ . . .. . .. ....... .. .. . .. . 71 
4.3.2.3 Disability Weights . ............... .. ..... . .. . .... . .. . . . 72 
4.4 CO-MORBIDITY ..... . ..... . .... . . ...... ...... . . ... . .... . .. . ... .. 73 
4.5 USE OF THE DALY FOR SETTING HEAL TH RESEARCH PRIORITIES .. .. . 74 
4.6 ISSUES OF EQUITY .. . . .. . . .. ..... . . .. ............ .. . .... . .. .... 76 
4.7 GENDER ... . . . . .. ..... . .... . .... ..... . . . . ..... ................ 77 
4.7.1 CONCEPTUAL ISSUES WITH REGARD TO GENDER .. ... . .. .... 78 
4.7.2 TECHNICAL ISSUES WITH REGARD TO GENDER . . ........ .... . 80 
4.8 POVERTY .... . . . .. . ......... . . . ..... . .. . . ..... .......... . .. ... 82 
4.9 USE OF THE DALY FOR RESOURCE ALLOCATION . ...... ... .. . .. . . . . 87 
4.9.1 COST-EFFECTIVENESS ANALYSIS (CEA) . . .... .. . ... . .. .. ..... 87 
4.10 AVOIDABILITY .. . .......... . ... .... . .. . .. .......... ...... ...... 88 
4.11 SYSTEMS ISSUES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 
4.12 CONCLUSION AND RECOMMENDATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . 89 
CHAPTER 5 
PRIORITY SETTING FOR HEAL TH RESEARCH IN SOUTH AFRICA 
5.1 HEAL TH RESEARCH PRIORITISATION IN SOUTH AFRICA ...... ... . ... . 92 
5.2 HEAL TH RESEARCH EXPENDITURE IN SOUTH AFRICA . . . . . . . . . . . . . . . . 92 
5.3 SETTING HEAL TH RESEARCH PRIORITIES IN SOUTH AFRICA: ENHR . . . 94 
5.4 NATIONAL RESEARCH AND TECHNOLOGY FORESIGHT PROJECT .... . 101 
5.5 MEDICAL RESEARCH COUNCIL PRIORITY SETTING . . . . . . . . . . . . . . . . . 104 
5.6 THE HEAL TH SYSTEMS TRUST (HST) RESEARCH PRIORITY SETTING . 104 
5.7 THE SOUTH AFRICAN RESEARCH RESPONSE TO THE AIDS PANDEMIC 105 
5.8 CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107 
CHAPTER 6 
CONCLUSIONS, RECOMMENDATIONS AND FUTURE DIRECTIONS 
FOR HEAL TH RESEARCH PRIORITY SETTING IN SOUTH AFRICA 
6.1 CONCLUSIONS 109 
6.2 RECOMMENDATIONS FOR RESEARCH PRIORITISATION . . . . . . . . . . . . . 112 
6.3 GENERAL RECOMMENDATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116 
6.3.1 POLICY ANALYSIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116 
6.3.2 HEALTH INFORMATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117 
6.3.3 CAPACITY DEVELOPMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117 
6.3.4 FUNDING/EXPENDITURE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118 
6.3.5 EQUITY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119 
6.3.6 COMMUNITY PARTICIPATION IN PRIORITY SETTING . . . . . . . . . . . 119 
6.3.7 THE GLOBAL RESEARCH AGENDA .. . ... . .. . .. . . . . . . . .. . .. .. 120 
6.4 RESEARCH TO IMPROVE HEAL TH RESEARCH PRIORITISATION IN SOUTH 
AFRICA ......... . . .. . .... . .. ... .... .. . .. . .. .. . . .. . ....... . . ... 121 
APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 
APPENDIX 1: The DALY formula . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124 
APPENDIX 2: Variables for Healthy Life-Years (HeaLY) Estimation . . . . . . . . . . . . 125 
APPENDIX 3: The Combined Approach: a practical framework for setting priorities 
in health research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126 
REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127 
CHAPTER 1 
SETTING THE CONTEXT FOR HEAL TH RESEARCH 
1.1 INTRODUCTION 
The health of the world 's people has improved more in the past four generations than in 
the whole span of human history. During this time, life expectancy for every income 
bracket has shifted steadily upwards and a given income buys better health than it did at 
equivalent levels 30 years ago. The rise in per capita income this century has been closely 
linked to increases in life expectancy, with the steepest increases occurring at the lowest 
income levels (Investing in Health Research and Development. Report of the Ad Hoc 
Committee 1996). 
The reasons for these global health improvements as well as the differences both within 
and between countries are multifarious. According to the World Development Report 
(WDR): (1993) "These successes, (in the health sphere), have come about in part because 
of growing incomes and increasing education around the globe and in part because of 
governments' efforts to expand health services, which , moreover, have been enriched by 
technological progress" (WDR 1993 P 1 ). 
In addition , scientific research has resulted in technical innovation and improved knowledge 
about health that has changed peoples' behaviour which has led to improved health status 
(Investing in Health Research and Development. Report of the Ad Hoc Committee 1996). 
While the impact of research is relatively well known , its economic value to society is less 
widely appreciated (Investing in Health Research and Development, Report of the Ad Hoc 
Committee 1996). Improved health leads to better utilisation of human capital, increased 
productivity and it frees up resources that would otherwise be used to treat illness. Also , 
better health results in improvements in school enrollment and attendance. Good health 
care is a necessary condition for equality of opportunities and hence is an essential 
element in the fight against poverty (WDR 1993 and Frenk 1995). Research brings another 
kind of wealth to society, in that a culture of research provides a rational , knowledge-based 
framework for progress in health (Investing in Health Research and Development. Report 
of the Ad Hoc Committee 1996). 
1 
Health-care priorities refer to the selection of health services that will be provided first in 
order to improve health benefits and the distribution of health resources . "Health research 
priorities , on the other hand refer to diseases, injuries and risk factors that produce a 
significant burden of disease but lack an effective intervention for their control. " (Bobadilla 
1996 p 45). Health research priorities also include the investigation of ways of improving 
the overall effectiveness of health systems. 
The 1990 report of the Commission on Health Research for Development (CHRD) entitled : 
Health Research : Essential Link to Equity in Development, emphasised that for the world 's 
poor, the benefits of research offer a potential for change that has largely gone untapped 
(Essential National Health Research and Priority Setting 1997). While more traditional 
views appear to regard research as contributing to a body of knowledge or generating 
information that may be useful for decision makers, others see it as an instrument used for 
social and political change by different social groups for different purposes (How to Boost 
the Impact of Country Mechanisms to Support ENHR 1999). A third perspective is that 
these views are not seen to be "in opposition to each other but as a spectrum of roles that 
research plays" (ibid P 15). 
A worldwide study of research and development expenditures reported that only 5% of the 
US $30 billion global investment in health research in 1986 went to health problems unique 
to developing countries where an estimated 93% of the world's preventable mortality 
occurs (Investing in Health Research and Development. Report of the Ad Hoc Committee 
1996). Even though the burden of disease is overwhelmingly in the Third World, investment 
in health research focuses mainly on the health problems of industrialised countries. In the 
early 1990s, in response to this skewed expenditure in health research , the Commission 
on Health Research for Development, recommended a strategy of ENHR (ENHR 1991 [b]) 
to aid the reform of health research policy in developing countries (Health Research : 
Essential Link To Equity In Development 1990). 
A 1992 estimate indicates that global spending on health research by the public and private 
sectors amounts to about US$56 billion per year. Less than 10% of the global health 
research spending is devoted to diseases or conditions that account for 90% of the global 
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burden of disease, the so-called 10/90 gap (The 10/90 Report on Health Research 2000). 
These more recent figures show that the gross mis-allocation of resources with the 
concomitant human and economic costs , has not been rectified . The Global Forum for 
Health Research Foundation was established in 1998 with the main objective to help 
correct the 10/90 gap. 
The global epidemic of the acquired immune deficiency syndrome (Al OS) is likely to further 
exacerbate the existing health differentials between rich and poor countries . It is predicted 
that the huge gap in human immune deficiency virus (HIV) infection rates and AIDS deaths 
between rich and poor countries is likely to grow even larger in this century. This differential 
is particularly pronounced between Africa and the rest of the world . Sub-Saharan Africa 
continues to bear the brunt of HIV/AIDS with some 23.3 million infected Africans. This 
amounts to almost 70% of the global total of HIV positive people in a region that is home 
to just 10% of the world's population (AIDS epidemic update 1999 P 5 and P 14 ). 
The epidemic is particularly severe in South Africa. It is estimated that 3.6 million South 
Africans are infected with this deadly virus. The HIV epidemic has increased 30-fold since 
1980. HIV rates have soared from 0.76% in 1990 to 22 .8% in 1998. In particular, there 
has been a leap in infection rates of young women in the 20-24-year-old age group from 
about 7% in 1992 to 21 % in 1995. One in five young mothers attending antenatal clinics 
is HIV positive (National Department of Health, April 2000). The United Nations 
Development Programme has calculated that less than 50% of South Africans currently 
alive are expected to reach the age of 60. A comparable figure for all developing countries 
is 70% and 90% for industrialised countries (AIDS epidemic update 1999). 
By the year 2005 almost 6 million South Africans could be HIV infected (Dorrington 1999). 
These statistics reflect not only the enormity of the AIDS epidemic in Sub-Saharan Africa 
but highlights the need for appropriate health research to address the escalating AIDS 
problem in desperately resource-poor Sub Saharan Africa (SSA). 
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1.1.1 POLICY 
In general , in the health arena there is a persistent gap between what should be attainable, 
given the present levels of knowledge, capacity and expenditure and the existing health 
status quo. Health policy analysis helps understand why appropriate, workable health 
policies are not affected . Policy analysis is a useful tool for health research and planning , 
and aids the priority setting process from decision-making and implementation through to 
evaluation . 
Health policy analysis involves the utilisation of health and multi-discipl inary information 
with analytical skills in interpreting the policy implications of facts and figures and an 
understanding of the policy process. Policy analysis is important for the setting of health 
research priorities as it explains the entire process. The prioritisation process includes the 
politics involved and both are intrinsic for determining what health research is ultimately 
carried out. "Research policy deals with research processes, the application of findings , 
research capacity and the decision making processes determining what research is done 
and how it is supported ." (Health Research: Essential Link to Equity and Development 
1990). 
With evidence-based policy making, policy is only partially driven by data. The focus should 
not be on health effect only, "but on perceptions, processes, systems and institutions" (Zwi 
and Mills1995) According to Lerer (1998 P 7) "Global health policy has to be driven by 
equity, human rights and gender sensitivity." 
When considering the data used for decision-making it must be noted that often health 
statistics are provided to decision-makers, the scientific community and the public by 
advocates with their own specific agendas (Murray 1996). 
Escalating health costs make the prioritising of health objectives the very basis of national 
health policy. For this South African study, although there is not a comprehensive and 
systematic health policy analysis with health research prioritisation a constituent part, the 
focus is on the latter. However, cognizance must be taken of the underlying pol itical 
process. 
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1.L ' EALTH AND DEVELOPMENT 
The Constitution of the WHO states that the highest attainable level of health is one of the 
fundamental rights of every human being (WHO Constitution 1948). 
On a global scale there are enormous health problems, especially in developing countries 
which carry a heavy burden of disease. As early as the twelfth century it was recognized 
that people at the lowest socio-economic levels in the community have higher death and 
illness rates (Kaplan et al. 1987). The poor - that sector of the population that can least 
afford to get sick - are the most likely to become ill and once ill , are unable to afford 
appropriate treatment. This reflects the vicious circle of poverty and ill-health. 
This pattern , the correlation between poverty and ill-health , has been observed throughout 
the world , regardless of whether the major causes of death and disability were from 
infectious or non-infectious diseases and regardless of how socio-economic position was 
measured (ibid). The most obvious explanations are insufficient medical care , low income, 
poor nutrition , inadequate housing, lack of sanitation and clean water as well as low levels 
of education . 
Health and development are two closely related phenomena. In numerous respects the 
development of a society determines the health of the people. The opposite is equally true -
the health of people is a precondition for development. Traditional health indicators (e.g. 
life expectancy, infant mortality rates) are also indicative of the development status of 
populations and their subgroups (Van Rensburg 1997). 
It is generally asserted that economic growth is essential for development. In many 
countries economic development has contributed to improving the health status of the 
population . However, certain development strategies may have adverse effects on the 
health status of certain population groups. For instance, industrialisation and urbanisation 
can cause ill-health and disease. In addition , some development policies may result in 
macro-economic adjustments that in turn result in cuts in the health budget of developing 
countries (Cooper et al. 1990). 
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In the review on the impact of development policies on health , Cooper et al. (1990) have 
identified and classified gaps in research to determine aspects of the relationsh ip between 
development policy and health that should be prioritized to clarify the research agenda in 
th is area. 
Frenk et al. (1989) have argued that: "Many of the emerging illnesses are a result of a 
defective process of industrialization that has placed more value on economic growth rather 
than on human welfare ." 
Health care and the economy are very closely linked. In contrast to other products, health 
services have a dual character. On the one hand, they constitute an essential component 
of social development and well-being ; while on the other, they represent a growing sector 
of the economy (Frenk 1995). 
There are conflicting views on the role of medicine in development. There are figures that 
indicate that modern medical care, (based on health research) , does not contribute much 
to the continuing increase in life expectancy in the developed world . A recent estimate, 
based on the analysis of major medical procedures, including medical forms of prevention , 
such as screening and immunisations, suggests that the whole modern medical effort adds 
no more than about five years difference to modern life expectancy (Bunker et al. 1994). 
McKeown et al. (1975) pointed out that the vast bulk of the decline in mortality from 
infectious diseases came before medicine had effective forms of treatment or 
immunisation . He argued that this meant the change was not the result of the application 
of medical science. People remained well because of better nutrition and a healthier 
environment (McKeown, 1976[a]). 
However, McKeown, (1976[b]) recognized some of the technical problems in his earlier 
analysis. Furthermore, he was challenged by Szreter (1988) on the basis that he failed to 
recognize the importance of the role played by public health campaigns and chang ing 
personal hygiene in the mortality decline in Britain . 
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Caldwell (1993) says that although Szreter once again drew attention to public health 
activities, especially at the level of local government, he did not discuss broader social and 
behavioural change. 
Caldwell (ibid) maintains that there are additional factors besides medical and public health 
interventions on the one hand and per capita income on the other, that determine health 
and risk of death. Evidence for this has come largely from comparative studies of the 
contemporary Third World. A study by Caldwell (ibid) identified eleven countries with health 
achievements far beyond what would be predicted by per capita income. This study 
showed the strongest correlation with health success was the educational levels of women 
of maternal age. 
As can be observed from the above discussion, the processes determining health status 
are complex and long term (Barker 1996). It is important to bear in mind the element of 
time when examining the factors that impact on health status. Wilkinson , (1996) points out 
that in effect, diminishing health returns to income at any point in time are accompanied 
by increasing returns over time. 
Murray and Chen, (1993) suggest that multiple factors may determine the relationship 
between income and longevity, including the effectiveness of public policies and of 
expenditure on health. 
Another theory on the determinants of health status is from Wilkinson, (1996) who asserts 
that: "Among the developed countries, it is not the richest societies that have the best 
health, but those that have the smallest income differences." 
1.2.1 CHANGING VIEWS ON DEVELOPMENT 
Barker, (1996) has traced a brief history of changing theories of economic growth versus 
equity for development. In the 1960s development was seen as virtually synonymous with 
growth and growth promoting policies were the order of the day. While economic growth 
would not initially reduce poverty, the income of the poorest would rise over time. This 
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process is termed the 'trickle-down effect'. During this process inequality may increase 
further. 
By the 1970s it was clear that little, if any, such trickling was happening and in mid-1970 
a basic needs approach was developed with a focus on production at all levels of society. 
Investment in the health and the education of the poor was promoted . 
Once again in the 1980s, policies were aimed at the highest possible growth rates , with 
growth taking preference over equity. From 1980-83 there was a recession , which resulted 
in an intolerable debt burden among the poor nations. By the mid-80s it became apparent 
that the adjustment policies that were part of the servicing of the developing nation 's debt, 
were causing them too much hardship. By the 1990s there were renewed calls for equity 
to be re-established as a development goal. The WHO's Health for All , through primary 
health care by the year 2000, envisaged an equity-orientated health strategy (Alma Ata 
1978). 
The World Bank has rapidly emerged as a dominant force in the health policy arena , 
advocating investment in the health of the poor as a means of development (Zwi and Mills 
1995). In recent years growth with equity has been espoused by agencies such as the 
World Bank (Barker 1996). Equity has become a vital constituent of economic development 
and an important aspect of health policy for health research priority setting. 
1.2.2 EQUITY 
The terms "equitable development" and "equity" are bandied about in the context of 
resource allocation. It is important to have a sense as to what they mean. 
The allocation of health resources involves a concept of justice. "Health resources are 
allocated according to various mechanisms or criteria such as productivity or other ethical 
principles such as the principle of justice put forward by John Rawls in 1971 in 'A Theory 
of Social Justice.' Using Rawl's principles of justice, society should maximize the expected 
welfare level of the worst-off person in society. Thus when conflicting interests occur, 
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effective health care would be distributed to those who are worst off' (Patrick and Erickson 
1993). 
There is ample evidence from the established market economies that a more egalitarian 
polity is associated with better health standards (Wilkinson 1996). Caldwell , (1993) 
demonstrated that a relatively egalitarian political culture is a precondition for superior 
health achievement by low income countries (Legge 1993). 
In most parts of the world, equity is accepted as an important social and economic goal for 
the health-care system. The concept of equity means different things to different people. 
For example, equity can refer to resource allocation and distribution. One can also examine 
equity in terms of outcome, such as health status (Lalloo 1995). 
Price, (1998 P 712) defines equality as being "concerned primarily with treating people 
equally with respect to some characteristic in which they are alike" and equity is "concerned 
more with finding some principle of fairness that could be applied to all people 
consistently." Equality in health care could be defined as the equal provision of health care 
regardless of need and equity as the provision of health care with respect to need 
(Lowen son 1991) (Read health-care or health research). "Equity refers to fairness and 
justice. It calls for the recognition of differential need, such as those of disadvantaged 
population groups in addition to equality of rights" (Bryant et al. 1997). 
Inequity refers to differences in health that are not only unnecessary and avoidable but also 
considered unfair and unjust (Whitehead 1990). Equity in health can be defined as equal 
expenditure per capita, equal expenditure for equal need, equal access for equal need , 
equal utilisation for equal need or even equal health status (Mooney and Drummond1982). 
Equity can be built into health research priority assessment through the ENHR initiative. 
Economic efficiency does not include any principle of equity in health resource allocation. 
An economically effective allocation of resources means that no one in the community can 
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be made better off without making someone else worse off (Patrick and Erickson 1993). 
In order to achieve social justice in the sense of seeking health for all , it will be necessary 
to divert considerable resources to the most disadvantaged in society. However, the DALY 
and similar measures which target the use of resources to maximize the benefits gained , 
is likely to help those who can most benefit, over and above those who are in greatest need 
(Barker et al. 1996). 
In addition , it will be vital that equity be achieved in many other sectors that impact on 
health such as housing, income, education and the supply of water and sanitation . 
"Each society must achieve a sufficient level of consensus about what equity means for 
that society to take effective action to reduce inequalities" (Essential National Health 
Research and Priority Setting 1997). The 1990 Report of COHRED, Health Research: 
Essential link to Equity in Development, concluded that research "will strengthen the ability 
- and the resolve - of developing countries to meet the needs of the most disadvantaged 
and , reinforced by international scientific and financial aid accelerate progress towards the 
fundamental goal of equity in health" (quoted in Essential National Health Research and 
Priority Setting 1997). Accordingly, the question of equity is of vital importance when 
setting research priorities in South Africa. 
1.2.3 HEAL TH AND DEVELOPMENT IN SOUTH AFRICA 
The mortality profile in South Africa shows a combination of First and Third World diseases 
(Bradshaw et al. 1984 ). These include poverty-related diseases, as well as chron ic 
diseases related to an industrialised lifestyle and the effects of trauma and violence. The 
latter relates to the social and political transition that is underway in South Africa . 
Demographic differences between race groups and the uneven development of 
geographical areas in South Africa reflect the socio-economic disparities arising from the 
apartheid policies of the recent past. 
As discussed earlier, Cooper et al. (1998) have shown that some developmental policies 
can be detrimental to the health of sectors of the population . These would include land 
distribution and population resettlement policies which formed part of the separate 
development programme and , as such, are particularly relevant in the South African 
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context. Cognisance must be taken of them in order to determine which health problems 
are to be addressed first. 
It is important that health be incorporated into a country's developmental policies. The 
Reconstruction and Development Program (RDP) was initially promoted as the 
development initiative of the post-apartheid government (The RDP 1994). Although health 
was included in the RDP, there was little detail concerning health research . However, 
within two years, the separate ministry set up to implement the RDP was disbanded . RDP 
principles were still e·ntrenched in the form of policy documents and legislation . In mid-
1996, the government presented its new Growth and Redistribution Programme (GEAR). 
This signalled a significant shift in the African National Congress (ANC) policies towards 
development, with economic growth being the primary thrust. Social development, which 
includes health, clearly takes a secondary position within GEAR. Although redistribution still 
features prominently in GEAR strategy, it seems likely that the macro-economic 
adjustments with the reduction of the budget deficit and the curbing of state expenditure 
may seriously affect many of the RDP projects (Van Rensburg 1997). There is general 
agreement that GEAR will impose additional hardships on the poor rather than alleviating 
the inequities inherited from apartheid (Van Rensburg 1997). The National Progressive 
Primary Health Care Network, (NPPHCN), states that, "the premise that economic growth 
is an obligatory precursor to development is false;" instead, "when equitable development 
is pursued with vigour, economic growth will occur as a consequence" (Macro-economic 
policy and its impact on health development, employment, redistribution and crime. P 1 ). 
1.2.4 POVERTY AND INEQUALITY IN SOUTH AFRICA 
The Gini-coefficient is a measure of income inequality. It ranges from 0-1, with O 
representing absolute equality and 1 representing absolute inequality. The Gini-coefficient 
for South Africa is currently 5,8 the second highest in the world. "While economic growth 
contributes to poverty reduction, it may not necessarily reduce inequality" (Poverty and 
Inequality In South Africa 1998). 
Achieving a reduction in poverty and equality with social and distributive justice is a 
fundamental challenge in South Africa without which, international experience suggests, 
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the human development, economic and employment goals of the government may be 
hindered (Poverty and Inequality In South Africa 1998). 
The South African government is committed to poverty reduction and a more egalitarian 
distribution of income and wealth . Since 1994 the government has been committed to 
prioritise the health needs of vulnerable groups such as the rural, peri-urban and urban 
poor, and women and children. 
1.2.5 A MODEL OF HEAL TH CHANGE 
Decision support through models is widespread in many areas including the health sector. 
A model represents only a simplistic representation of a complex system. However, it 
provides a basis for recognizing interactions and processes (Lerer 1996 personal 
communication) . A systematic approach to interactions between parts of a complex cluster 
is vital for successful strategy development (Porter 1993 - quoted in Lerer 1997). 
Current epidemiological complexity requires more formal analyses of health priorities than 
ever before. In this context, the most viable scenario is the development of health systems 
that are pro-active, that anticipate problems and do not just react to crises (WDR 1993). 
Factors such as income, education, employment status and occupation universally shape 
the age and sex patterns of populations through their impact on fertility and mortality. In 
populations undergoing demographic transition, there is generally a decline in mortality 
followed by a drop in fertility resulting from improved socio-economic conditions. As fertility 
declines the population ages. The population age structure and corresponding cause of 
death patterns during the demographic transition are largely a function of the decline in 
fertility. In addition, with industrialization and urbanization a decline occurs mainly in the 
mortality of infectious diseases among the younger age groups. There is a consequent 
shift in the cause of death profile to chronic diseases and this forms part of what is called 
the epidemiological transition. 
The epidemiological transition has been broadly described as referring to the complex long-
term changes, (over decades or even centuries), in the patterns of health and disease as 
communities transform their social, economic and demographic structures. Om ran, (1971) 
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initiated the theory of epidemiological transition . He posited a set sequence of events 
starting with a preponderance of infectious diseases, followed by an era when chronic and 
degenerative ailments predominated. 
On the basis of observations from some large middle-income populations Frenk et al. 
(1989) proposed modifications to Omran's theory with the protracted-polarised model of 
epidemiological transition. This model is characterized by the coexistence of infectious and 
non-communicable diseases in the same population persisting for a long time. In the 
protracted model more affluent sections of the population would have completed the 
transition, while economically disadvantaged groups continue to suffer from pre-transitional 
pathologies. This bi-polar model applies to South Africa. 
Prioritisation in health research must be viewed within the context of the health transition . 
The epidemiological transition together with the demographic transition have become 
known as the health transition (Bradshaw et al. 1995). The health transition refers to 
changes in fertility, mortality, cause of death composition, disability and the health system's 
response to these trends (Murray 1996 and Frenk 1989). 
Figure 1 is a model of health change from Mosley et al. (1993). The first section in the 
figure refers to the determinants of health status - the driving forces behind health . The 
protracted-polarised epidemiologic transition describes the current South African scenario 
of health change. 
Figure 1: Relationships among the Demographic, Epidemiologic and Health 
Transition 
Urbanization 
Industrialization 
Rising incomes 
Expansion of 
educa1ion 
Demographic transition 
Infectious 
disease 
mo~ity 
decflnes 
Health transition 
Fertility 
declines 
Improved 
medical and 
public health 
technolooy 
---------------------------
... 
Source: Mosley WH et al. (1993) 
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The model is useful for the analysis of health status in developing countries but the 
historical context, such as colonialism , needs to be taken into consideration as well. For 
example, in Africa there has been urbanisation without industrialisation wh ich is not shown 
in the model (TIME 1994 ). The health transition occurred in industrial ised countries after 
there had been substantial economic improvements. 
According to Frenk: "Perhaps the major challenge is to make the health-care transition 
respond to the epidemiological transition in a way that reduces the inequities brought about 
by the protracted-polarised model" (draft Frenk circa 1995). 
Transition theory as it stands, does not explain how social and economic changes are 
related to health transformation (Bradshaw et al. 1995). Murray and Chen, (1993) have 
proposed that three established theories of mortality change, viz the income and food 
theory, the dissemination of modern technologies and socio-cultural change that includes 
changing beliefs and health behaviour, explain some aspects of the worldwide phenomena 
of long term general mortality decline in an interactive way. 
South Africa may not be in an economic recession and while there has been some 
redistribution of wealth, there is evidence that inequality is not being reduced but is being 
structured differently (Sunday Times 1999). 
A feature of the protracted-polarised model is the juxtaposition of a developed and an 
underdeveloped sector, that comprise the health arena. One cannot ignore the developed 
sector when setting priorities. This is of particular relevance to South Africa where one 
would want to at least maintain some areas of excellence in the developed sector and 
promote some specific research areas to the level of internationally competitiveness. 
In developed countries the demand for health care is growing. Bobadilla (1996) refers to 
the 'health utilisation paradox'. As income per capita rises, the utilisation of health care 
services and the unit cost of treating an individual also increases. 
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This can be explained by four socio-economic changes, which correlate strongly with 
income: 
1. An aging population consumes more services and more costly services (Mosley et 
a/. 1993). 
2. As people increase their income, then tobacco consumption , alcohol abuse, lack of 
exercise and excess animal fat consumption becomes more prevalent. This stage 
of regressive behaviour places a heavy burden on health services (Bobadilla and 
Costello 1996). 
3. More education and information lead to greater health care demand (Berman and 
Ormond 1988). 
4. New drugs and techniques in clinical medicine lead to higher costs of health-care 
with marginal benefits to population health status (Bronzino et al. 1990). 
The above scenario applies in part to South Africa and serves to further complicate the 
priority-setting process for research . 
1.3 HEAL TH RESEARCH AND HEAL TH SYSTEM REFORM 
Many countries have health systems that are in crisis with escalating costs and as a result, 
health system reform ranks high on many political agendas. At the start of the new 
millennium virtually every country whether industrialized or less developed , is engaged in 
a process of health system reform (Zwi and Mills 1995). 
Recent analyses of health sector reform provide useful conceptual maps of the health 
system and health policy (Frenk 1993 and 1995; Walt 1994). Frenk (1995 P 258) states 
that "if health systems are to keep up with the wave of innovation that has swept through 
economics, politics, culture and technology, they must be renewed." 
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FIGURE 2: Model of health system reform 
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Fortunately, there are a number of analytical tools that can be used by the policy 
community to increase the quality of their decision-making. According to Frenk (ibid), one 
of the current challenges is to integrate these different approaches into a coherent 
framework for policy analysis. Figure 2 shows the approach used to develop and apply 
such a framework for a study in Mexico from 1993 - 1994. This is a clear, comprehensive 
model which , with some modifications, could be applied to South Africa . From the model 
it can be seen that health research prioritisation is an integral part of the process of health 
system reform. In Figure 2, priorities for research and development are depicted as 'the 
intelligence' arm of the system. (The national burden of disease, 'the problem' together 
with cost effectiveness analysis are tools that help determine research and development 
priorities) . 
According to Barker (1996) , the conceptualisation of a system clarifies a particular area for 
further analysis. Barker states that thinking through the environment in which the system 
operates refines the model further. Once one system has been modelled , the systems that 
represent its component parts can in turn be modelled , taking the analysis of actions and 
interventions to a more detailed level. 
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Priority setting for health research cannot be examined in isolation as it is part of the 
broader health system. The health system is in turn affected by the broader social context 
within which it operates. 
A detailed model for health research prioritisation in South Africa needs to be developed . 
This model should be part of a more general health systems model. It should incorporate 
all stakeholders relevant to the research prioritisation process, the different levels at which 
interactions occur as well as the environment in which the system operates. This should 
facilitate transparency for policy decisions for research prioritisation . Terms used in the 
model should be clearly defined as part of consensus-building and all terms of reference 
should be clearly stated . As part of the initial stages of determining health research 
priorities it will be necessary to examine how health research will be classified . The model 
should include the means of channelling funds and controlling budgets and research 
evaluation procedures. 
1.3.1 ESSENTIAL NATIONAL HEALTH RESEARCH 
Frenk wrote that a research agenda must be an integral part of every initiative to reform 
and renew health systems. He added that, "What is essential about ENHR is its 
commitment to goals like equity, quality and efficiency, which are precisely the same ones 
that the reform movement promotes" (Essential National Health Research and Priority 
Setting 1997 P 3, from Research into Action 1997). 
ENHR represents an integrated strategy for organising and managing health research to 
promote health and development based on equity and social justice. The essence of ENHR 
is a dynamic partnership between policy makers and service-providers, researchers and 
the community. Setting priorities is identified as one of seven elements of ENHR which also 
includes ENHR promotion, a national ENHR mechanism, strengthening research capacity, 
networking, funding and evaluation of ENHR (ENHR 1991 [bl). The Council on Health 
Research for Development, (COHRED) is an international non-governmental organisation , 
(NGO) that aims to support, broaden and strengthen the linkages and competencies of 
various stakeholders in the country and at international levels (Essential National Health 
Research and Priority Setting 1997). The primary goal of global priority setting is to help 
countries with the greatest health needs and fewest resources; i.e. international health 
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priorities should reflect national priorities. (Essential National Health Research and Priority 
Setting 1997 1990). This goal is as relevant now as it was a decade ago. 
Setting priorities has been acknowledged as an important element of ENHR but only 
guiding principles on general procedures have been provided . A recent review of 
experiences from several countries has provided practical suggestions on how to proceed 
with such an exercise (Essential National Health Research and Priority Setting 1997). 
Bland, (Research in Action 1997) in particular, warns that if ENHR is to address the 'felt 
needs' of communities , it is important to consult and involve them in the process of setting 
priorities. 
A useful framework for priority using the ENHR strategy is shown in Figure 3 (Essential 
National Health Research and Priority Setting 1997). The framework reflects 'demand-side' 
thinking" focussing on health needs, peoples' expectations and societal trends in contrast 
to supply-side thinking alone, with its focus on new knowledge or new technology" 
(Essential National Health Research and Priority Setting 1997 P 4). 
Where ENHR strategy is used, the different stakeholders in research are involved in 
consultative group processes utilising qualitative and quantitative data, in order to 
determine health needs, problems and priority research. 
The framework depicted in Figure 3 also includes the links between the national and global 
research agendas. However, a section for the evaluation of the research is lacking and can 
be built into the current model. The framework should represent a systematic, flexible , 
comprehensive process for setting, implementing and evaluating health research priorities 
in South Africa. 
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1.4 PRIORITISATION 
No matter how desirable health research is to society, there is always the problem of 
scarce resources and competing uses for available resources. In general the scarcity of 
resources means that not everybody's needs can be met. There is a need to decide what 
should be dealt with first. This need to prioritise and so allocate resources optimally is 
particularly relevant in developing countries where there are relatively less resources and 
more basic needs. 
In general , planning can be considered a rational response to scarcity and priority setting 
an integral part of planning. Unfortunately there is limited literature about the theory of 
prioritising health research. In the health arena it has been recognised that priority setting 
is often not given sufficient attention (Green 1992). Furthermore, as Mooney et al. (1997) 
have asserted , the important issue is not whether to prioritise, but how to prioritise. This 
assertion is made in the context of health care prioritisation and it applies equally well to 
health research prioritisation. Prioritisation is an expensive process in terms of time and 
money and is ongoing. The setting of priorities for health research emerged as a pivotal 
issue for analysis. 
The health priorities of a country and the health research priorities are linked and overlap 
to some extent. However, they are not one and the same and therefore it will be necessary 
to explore this relationship . 
1.5 OBJECTIVES AND METHODS 
The overall aim of this thesis is to examine prioritisation for health research with specific 
reference to South Africa . The specific objectives and sub-objectives are enumerated 
below. Although there will not be a systematic policy analysis for health research 
prioritisation in South Africa, it is however an important underlying issue that is referred to 
throughout the study. 
1.5.1 OBJECTIVES 
1. To describe the technical approaches used for prioritisation in health research and 
examine the classification of health research . The development of a systematic 
process and the identification of appropriate techniques for prioritisation for health 
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research is explored. In addition , in order to include the international health research 
prioritisation experience, there is an examination of an initiative which reviewed 
global research priorities for developing countries. 
2. To examine how burden of disease quantification fits into the process of setting 
priorities. To explore the role of the DALY and other composite measures of health 
outcomes in priority setting for health research . To investigate the extent to which 
additional information is contributed through composite measures and assess the 
impact on priorities. Specifically, to examine the extent that disability/morbidity data 
contribute to an assessment of the burden of disease. 
3. To provide a thorough critique of the DALY by analysing the technical and 
conceptual criticisms levelled at the DALY. 
4. To describe the process of setting research priorities that has occurred in South 
Africa. In particular, the use of ENHR to manage health research on a national basis 
is examined in the South African context as well as an investigation of the extent 
to which explicit prioritisation processes have been used. 
5. To develop a model for setting priorities through specific recommendations that are 
distilled from the various sections of the thesis. It is envisaged that this model 
incorporates an ENHR strategy and burden of disease methodology. This tentative 
model will serve to guide and improve the health research priority setting process 
in South Africa. To ensure that the various issues that are discussed become an 
integral part of the overall framework for prioritisation. To suggest directions for 
future research . 
1.5.2 METHODS 
The methods employed to examine the setting of health research priorities and apply them 
in South Africa range from extensive literature review to statistical analysis of data 
published from the GBD estimates. This variety of seemingly disparate methods, each 
make a unique contribution to assist in achieving a more complete analysis and 
understanding of this complex subject. An analytic framework to examine prioritisation in 
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health research was developed drawing on multiple disciplines, which included health 
policy analysis , epidemiology, public health , economics and statistics. 
1.5.2.1 Method for objective 1: Approaches to setting priorities 
An extensive literature review will be undertaken in order to examine the various 
classifications of health research and develop a framework for the approaches to setting 
research priorities. The literature review comprised a MEDLINE search , with subsequent 
follow-up of literature from the references of selected articles. In addition use was made 
of some relevant grey literature. 
1.5.2.2 Method for objective 2: Health outcome measures 
An epidemiological approach is employed giving a brief outline of the historical 
development of health outcome measures. These measures are compared in terms of 
utility for helping to determine priorities in the health arena. 
A statistical approach is used to assess the contribution of the constituent parts of the 
DALY. Premature mortality and disability will be analysed in terms of age, sex and disease 
group, specifically for Sub-Saharan Africa. The results of regression analysis using Years 
of Life Lost (YLLs) and Years Lived with Disability (YLDs) with mortality will be analysed 
to ascertain the contribution of composite measures for priority setting. 
Similarly, Life Expectancy versus the summary health measure, the Disability Adjusted Life 
Expectancy (DALE) calculated for all the WHO member, states will also be analysed. 
These analyses will investigate whether the disability component is important for 
determining population health status, the performance of health systems and ultimately 
health research priorities. 
1.5.2.3 Method for objective 3: DALY critique 
A detailed review of the critique of the DALY will serve to examine the burden of disease 
methodology including the way inherent assumptions affect the determination of priorities 
in health research . 
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The review method employed , is to group the criticisms gleaned from the relevant literature 
into technical and conceptual issues and to analyse what effect these issues have on 
priority setting. Suggestions to rectify the shortcomings of the DALY are made specifically 
for those criticisms that are of relevance for prioritisation . 
Particular attention is given to equity and women 's health . 
1.5.2.4 Method for objective 4: ENHR in SA 
Committee reports, green papers and other documents from grey literature will be reviewed 
to describe how health research priorities have been determined and funded in South 
Africa. As South Africa is undergoing social and political transformation after the demise 
of apartheid, a historical and a current perspective will be necessary to aid the 
understanding of the development of an indigenous process of setting health research 
goals. 
This section will include a brief history of ENHR in South Africa and a fairly detailed 
analysis in terms of the process for setting priorities for health research that emerged from 
the first priority setting Congress held in South Africa in 1996. 
1.5.2.5 Method for objective 5: Synthesis of an operational framework for health 
research prioritisation in SA. 
The basis of the tentative prioritisation model should integrate the following: The analytical 
framework for identifying health research to address health challenges. A suitable 
classification system of health research . The appropriate selection of health or burden 
measures. The ENHR strategy that is to be developed and implemented in South Africa 
should be included in the model. 
Additional recommendations for the suggested framework will include those arising from 
discussion of the components critical to the prioritisation process. 
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1.6 CHAPTER OUTLINES 
Chapter one introduces health research priority setting in the context of improving health 
and social justice. It provides the motivation for the choice of this particular topic and the 
specific objectives and methods used. The introduction includes an historical perspective 
on health and development and a working definition of health research . The sections that 
provided the necessary background for the thesis included a brief discussion of health 
research and the distorted global health research agenda. In addition , the role of health 
policy and health policy analysis for priority setting was touched on briefly. Following this 
was an exploration of the relationship between health and development, as well as the 
important issue of equity in the context of priority setting. There is also a perfunctory look 
at models of health change and health reform and the respective contributions made to 
understanding health systems of which research is an integral part. This chapter serves 
to integrate the general background information on health and development into the South 
African context. This includes an historical background of health research priority setting 
and some discussion on health research expenditure in South Africa. The discussion on 
health system reform applies particularly to South Africa, where re-prioritisation is an 
integral part of health system reform. The Essential National Health Research (ENHR) 
strategy is introduced and a blueprint for a framework for setting health research priorities 
incorporating ENHR in South Africa is presented. The role of research as a catalyst for 
change and the necessity that research anticipate and provide solutions for future health 
problems of mankind was highlighted. Setting priorities for health research, especially 
resource poor settings, is shown to be a most important issue, requiring further analysis. 
In chapter two, a model is presented that brings together various factors that need to be 
considered for appropriate intervention decisions, which includes health research , for 
improving health. This is conceptualised at a global level. The chapter comprises a 
detailed exploration of the approaches to setting health research priorities by examining the 
literature. It is observed that health research prioritisation can be viewed from different 
perspectives. The setting of priorities is determined by applying an analytical framework, 
classifying the research into specific types as well as incorporating the various criteria that 
are used to rank research needs. 
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The analysis of the global health problems in order to identify priority research needs by 
the WHO Ad Hoc Committee on Health Research WHO is used as a model in South Africa 
with some adjustments. This model utilises a sequence of specific steps as part of the 
priority setting process with separate exercises for the different approaches. 
Since the burden of disease is a key element of the health problem approach for setting 
priorities, it is important to examine the measurement of health outcomes. Chapter three 
commences by looking at the determinants of health status and defining different concepts 
of health. Thereafter the development of various measures of health outcomes are 
discussed. This discussion includes an historical perspective, the underlying theory as well 
as the appropriate use of these measures of health outcome. There is a detailed account 
of the DALY (Disability Adjusted Life Year) focussing on its advantages when compared 
to other similar measures. It is an important measure used by the Ad Hoc Committee on 
Health Research. It is the basic unit of measurement used to identify a health gap and is 
a composite measure of mortality and the disability associated with morbidity or injury. 
Besides the DALY, another important summary measure of health status is the DALE 
(Disability Adjusted Life Expectancy). Both the DALY and the DALE have a morbidity 
component. With the DALY the measure, mortality is augmented by years of life lost to 
disability and with the DALE, life expectancy is adjusted for disability. The question arises 
as to what the morbidity component adds to the measures. This is analysed using the 
statistical tool of regression analysis. 
From the discussion on the development of composite measures, it can be ascertained that 
whilst some are appropriate for measuring health status, others measure the burden or 
health gap. Mortality may well be sufficient as a measure of health status. However, it does 
not adequately capture the measure of health burden on its own. 
The champions of the DALY state that the DALY has the potential to describe the health 
status of the population i.e. the quantity of ill-health and the burden of disease, set health 
research priorities and assist with the allocation of resources as well as contributing to the 
evaluation of interventions and programmes for improving health. In chapter four, these 
assertions are appraised with the emphasis on the DALY as a measure for allocating 
resources and more specifically for setting health research priorities. During the last few 
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years there has been extensive debate over technical and conceptual issues concerning 
the DALY. The main criticisms concern the assumptions and underlying values in terms of 
the application of the DALY. 
In the next section of chapter four, the focus moves from the setting of priorities for health 
research to the issue of who sets priorities for whom This concerns the DALY and resource 
allocation. In this context, the issue of equity is addressed briefly. In particular, the gender 
and poverty implications of the DAL Yare appraised. This was done by means of an applied 
critique of the DAL Yand women's health. Although gender concerns both men and women , 
women's health priorities are highlighted as gender differences are especially significant 
for women as they result in inequality and discrimination. 
In a separate analysis, it was demonstrated that the burden of disease based on DAL Ys 
does not differentiate the needs of the poor. The increasing health disparities between rich 
and poor countries and the feminisation of poverty cannot be ignored. The DALY can be 
used to help mitigate inequality in health through, for example, stratifying data and utilising 
data that highlights inequality in health. In order to use the DALY effectively for resource 
allocation , it has to be used in conjunction with CEA and include the assessment of 
avoidability. Chapter four concluded that the DALY is a most useful adjunct tool for setting 
country- specific health research priorities. 
Chapter five describes the South African process of health research prioritisation and 
reflects on the recent experiences in South Africa so that priority setting can be improved 
and also contribute to the numerous research prioritisation initiatives undertaken in other 
countries. In particular, ENHR has been identified as a necessary strategy to manage 
health research on a national basis so as to meet the needs of the country. 
Recommendations are made as to how South Africa can develop an indigenous model for 
prioritising and enhance the implementation of ENHR. 
ENHR in South Africa is to be implemented against the background of recent development 
initiatives which impact on the health arena as well as the current patterns of health 
research expenditure. The general procedures and the results of the first ENHR priority 
setting Congress in South Africa are presented and discussed. 
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In addition , there was discussion on the health research priority setting of the Foresight 
project, the MRC and the Health Systems Trust. 
AIDS is emerging as a huge global health problem. As such it serves as an example of the 
current process of research prioritisation in South Africa. 
The concluding chapter is a synthesis of the preceding chapters. This is achieved by 
highlighting the important recommendations to aid the development of a systematic 
process of setting health research priorities in South Africa. The future directions for health 
research prioritisation are also pinpointed. 
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CHAPTER 2 
THE APPROACHES TO SETTING HEAL TH RESEARCH PRIORITIES 
2.1 SETTING HEAL TH RESEARCH PRIORITIES 
Since priority setting does not occur in a vacuum, it is necessary to see it in the context 
of the health system, the myriad of factors that impact on health and development, the 
sources of knowledge available to address health problems and the constraining values. 
A WHO report on a health policy agenda to support global health development provides 
a diagram (Figure 4) that captures the inter-relationship between values, disciplines and 
the various determinants of health and incorporates the levels of health analysis with 
these determinants and how they impact on the central issue of 'Health for All'. All 
these factors interact to guide the choice of appropriate intervention decisions on health 
problems. 
FIGURE 4: The factors that impact on health and guide the choice of appropriate 
intervention decisions on evolving health problems 
Biomedical sciences 
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All scientific disciplines shown in the octagon in Figure 4 contribute to increasing the 
knowledge base. Decisions on action concerning health problems which includes 
research priority setting based on multi-disciplinary information are tempered by values 
of social and ethical acceptability, effectiveness and validity, environmental sustainabil ity 
and affordability. 
Figure 4 is a fairly comprehensive diagram and is useful as an explanatory device. 
However, it does not provide insight to the setting of health research priorities, or an 
appraisal of systems of prioritisation. According to Walt, (1994) health policy is about 
process and power. It is concerned with who influences whom in policy making and how 
this happens. In contrast, policy is about content for many people and although they 
agree "that politics cannot be separated from policy there is little explicit discussion in the 
literature about political systems, power and influence and people's participation in policy 
making" (Walt 1994 P 1 ). 
In terms of the prioritisation of health research, main stream literature suggests a 
technocratic approach to priority setting with burden of disease data, cost effectiveness 
analysis and essential packages. Little attention is given to other dimensions of priority 
setting such as the political context, the decision making process, the institutional and 
management implications of proposed priorities, the ethical implications of various 
methods and the role of social values in the allocation of health resources (Bobadilla 
1996). 
Walt and Gilson (1994) have argued that with the focus on the technical aspects of 
policy content and the neglect of the process of policy development and implementation, 
this has resulted in the expected outcomes of policy not being realized or policy changes 
not being effectively implemented. 
Walt, (1996 P 227) describes "a simple framework for policy analysis which takes 
account of contextual factors , processes of policy-making and the influence of actors as 
well as substantive content. " The 'content', 'context' and 'process' can be conceptualized 
as the corners of an equilateral triangle, with actors, both as individuals and as members 
of groups within the triangle. 
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An examination of the process of health research priority setting involves analyses on 
how decisions concerning these priorities are arrived at, as well as who and what 
influences the decision-making process. While all the elements are extremely important 
the focus will be restricted to the decision-making dimension of prioritisation rather than 
the whole process of prioritisation . 
2.1.1 METHODS FOR SETTING PRIORITIES 
Ronayne (1984) identified two extreme methods for setting research priorities, i.e. the 
rational and the incremental. 
1. The rational method involves collecting all available information on what is 
needed and what is possible, identifying objectives and collecting data on what 
value is placed on these objectives by various groups. 
2. The incremental approach involves inching forward from what is happening now. 
The degree of movement at any time being determined by the political context, 
which includes not only ideology but also the different interest groups in society 
(Green 1992). 
Internationally, shifts towards a rational approach are becoming evident with the 
development of a range of tools to assist policy-makers in improving the policy process 
in general as well as setting priorities. However, Foltz (1996) reflected on the lack of 
impact of the technocratic planning tools developed for management in the 1960s and 
1970s and argued that prioritisation cannot be resolved by purely technical and scientific 
means as it is a political process that involves an underlying value system. 
According to Foltz (ibid), the rationalist approach is particularly well represented in the 
health sector and is employed to set priorities. This may reflect the influence of 
epidemiologists and economists in health planning at the expense of the more 
pragmatically orientated social sciences such as political science and sociology. 
The incrementalist approach has until recently prevailed in South Africa , Parry et al. 
(1992) have argued that the incremental approach is unsatisfactory as it discourages 
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innovation and action, priorities can be self-perpetuating and often do not meet public 
needs. They suggested that although the technocratic or rational approach is limited by 
the nature and quality of health information available and by the judgements made about 
such information, it would be preferable to use this approach . 
Nevertheless, the incrementalist view of the policy process has gained considerable 
currency as it aptly describes what decision-makers actually do, i.e. they engage in "an 
interactive process of mutual adjustment" (Foltz 1996 P 211 ). 
Green (1992) suggests realistic rational planning which combines technical skills with a 
recognition of the political process. Figure 5 is a diagrammatic representation of planning 
as a cyclical set of activities. Prioritisation is clearly placed in a continuous process of 
ongoing planning and evaluation. 
FIGURE 5: Diagrammatic representation of planning 
/ Situational analysis"'\ 
Evaluation Priority, 
( 
goal. and objective 
setting 
l 
Implementation Option appraisal 
and monitoring / 
~ Programming 
Source: Green (1992) 
According to Green (1992 P 34), the formalities of planning is only part of the process 
and the "relationship between planners, policy-makers, service-managers and the 
communities in the planning process is critical to the success of planning." These 
political components are an integral part of the planning cycle. However they are not 
reflected in the diagrammatic representation of the planning cycle shown in Figure 5. 
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2.1.2 LEVELS OF PRIORITY SETTING 
According to Ham, (1995[b]) priorities are set at a number of levels, ranging from the 
macro to the micro. Although Ham (ibid) refers specifically to different levels of priority 
setting for health care, the concept can be adapted for use in describing priority setting 
for health research . In the case of health research, these levels would reflect a 
combination of geographic levels and levels of health research organisation and are 
shown in Table 1. 
Table 1: Different levels of health research priority setting 
1. Global agenda (e.g. international agencies and multinationals) 
2. National allocation of resources to institutions (e.g. health-care, research or 
academic) 
3. Allocation to broad research programmes (e.g. AIDS, chronic diseases of 
lifestyle), targeted academic disciplines (e.g. health economics, paediatrics) 
or geographic levels (e.g. as province or district) 
4. Allocation to research projects within programmes or academic disciplines 
Adapted from Ham (1995[b]) 
The first level is a global one which includes international agencies and multinationals. 
Level two is the national level and incorporates the Department of Health, teaching 
hospitals, universities and research institutions such as the Medical Research Council 
in South Africa. Level three defines research areas and level four refers to very specific 
research topics. 
2.1.3 CLASSIFICATION OF HEAL TH RESEARCH 
For health research prioritisation it is useful to place health research into different 
categories according to the primary purpose of the research. As with any classification 
system there tends to be oversimplification. However, the classification of research 
types provides a framework for organising and planning health research. "Sometimes 
careful specification of a research problem itself suggests the forms of research needed 
to address it" (Essential National Health Research and Priority Setting 1997 P 13). 
32 
Health research can be divided into basic and applied research which are carried out 
in the laboratory, clinical and community setting (ENHR 1991 [a]). Basic or fundamental 
research refers to the creation of new knowledge and applied research refers to problem 
orientated research which leads to applications, i.e. defined as the application of existing 
knowledge. Applied research comprises both strategic and intervention research . 
Strategic research is the problem-solving component of research in which knowledge is 
generated about specific health needs and problems. Intervention research is focussed 
on the development and evaluation of interventions (Investing in Health and 
Development. Report of the Ad Hoc Committee 1996). 
The purpose of basic or fundamental research is to increase knowledge about questions 
of scientific significance. The purpose of strategic research is to increase knowledge 
about a particular problem in order to reduce the impact of the problem with further 
development and evaluation . The relative contribution of the problem-solving and 
knowledge-gaining components vary with the particular research project (ibid) . 
"Research efforts may be targeted for short, medium or long-term results. The longer 
term the research efforts, normally the higher the ratio of applied to basic research" 
(ACHR 1997 P 18). The serendipitous nature of basic research has often been referred 
to. However, curiosity driven or 'blue sky' research may well not result in important 
applications (ENHR 1991 [a]) . 
Aside from categorising research on the basis of the purpose, it is possible to categorise 
research according to type. For instance, an adaptation of Frenk's research types, 
includes biomedical, clinical, population and health systems/policy research (Barron et 
a/. 1997). 
In this framework research is divided into biomedical , clinical , epidemiological and health 
systems research. Biomedical research refers to health problems/conditions, biological 
processes and pathological mechanisms. Clinical research refers to the efficacy of 
diagnostic, therapeutic and preventative procedures. Epidemiological or population 
research refers to the frequency, distribution and causes of disease. 
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Each of these broad research types can be linked to specific academic disciplines and 
methodologies. These groupings of scientific disciplines can facilitate resource allocation 
for research infrastructure and capacity building as well as the subsequent evaluation 
of health research but are not directly useful in the prioritisation process. 
Barron et al. (1997) suggest that health systems research has two main components : 
health policy research and operational research . The latter refers to the delivery of health 
services, preferably at local level, for which there is a great need in South Africa (Barron et al. 1997). "Health policy research integrates the results of different types of 
research to select policy options" (ibid P 236). It also focuses on inter-sectoral issues, 
for example, the interaction of the health services with the environment (Barron et al. 
1997). 
The modified version of Frenk's classification system can also be looked at in terms of 
the level of analysis. The biomedical and clinical research categories concern the 
individual or sub-individual level. The population or epidemiological and health systems 
research categories covers the population or health system level (Barron et al. 1997). 
An alternative way of grouping the biomedical and population research categories is to 
refer to health problems or conditions while the clinical and health systems research 
categories refer to the health-care responses. 
2.1.4 ANALYTICAL FRAMEWORKS 
Health research priorities can be examined from different perspectives. According to the 
literature , one approach is to rank the health research needs according to the priority of 
the health problem (Feachem et al. 1989). Alternatively, priorities in health research can 
be set by prioritising groups of people (ibid). A third means of prioritising in health 
research is to examine the potential health gain from different types of interventions that 
have broad effects such as improvements in water supply, sanitation, maternal 
education and food supplementation (Murray 1990). A fourth perspective is the health 
systems approach which ranks health systems issues according to the importance of 
the problem. An example of this is health financing which would impact on the entire 
health system (Janovsky and Cassels 1996). Although four perspectives have been 
identified , it would appear that there are basically two distinct perspectives viz. a health 
problem or a health systems approach. Prioritising groups of people involves first 
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targeting certain groups such as women and children or rural populations and thereafter 
setting priorities using either a health problem or systems approach . The broad 
intervention approach could be considered similar to the systems approach . 
Feachem et al. (1989) defines a health problem resulting from a non-trivial cost or 
consequence of a state of ill-health. They provided a framework whereby a health 
problem can be separated into four types of research depending on the extent and 
nature of the knowledge needed to overcome the problem. These are shown in Table 2 
and range from describing the magnitude of the problem to operational research 
examining the delivery of interventions. The determinants of a health problem include 
both biomedical and psycho-social components. Interventions can further be divided 
into: Health Promotion ; Prevention of Disease, Treatment and Rehabilitation . 
Another category for research, described by Feachem et al. (ibid) is health services 
research which is not derived from a particular health problem but from a concern about 
the overall financing, organisation and operation of the curative and preventative 
services. These five categories have overlapping boundaries. To some extent there is 
a natural sequence implied with one type of research leading onto the next a kind of 
hierarchy in terms of overcoming the problem (ibid). Combinations of different types of 
research are sometimes necessary to solve a particular research problem. 
Janovsky and Cassels (1996) referred to health policy and systems research in a more 
comprehensive manner than the fifth category designated by Feachem et al. (1989) . The 
former incorporates all aspects of a health system in terms of demand , supply and the 
mediating organisations. Table 2 summarises and combines Feachem et al. and 
Janovsky and Cassels' classification of health research. 
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Table 2: Types of health research 
Health problem approach: . Knowledge arena . . (Feachem et al. 1989) 
Health problem research describes the magnitude of the problem 
Aetiology research focuses on pathological processes (biomedical and 
psycho social) 
Intervention research looks at the development of effective interventions 
Operational research examines the delivery system 
Health systems approach:. Knowledge arena (Janovsky and Cassels 1996) , .. 
,. ' . ,,, .. 
-
Demand side includes individuals and households and populations 
Mediating organisation comprises the institutional purchasers and the state 
Supply side involves resource institutions, service providers and 
agencies in sectors outside health 
However, it is difficult to derive specific health system and policy research projects from 
Janovsky and Cassels' health system classification. Feacham et a/s'framework can also 
be applied to health systems and policy. The foci of research for health systems can be 
grouped into the following categories: Magnitude of the problem; Understanding the 
system factors; Development and evaluation of interventions and Implementation 
Research. Implementation Research can be divided into two groups namely, Operational 
and Policy Research. 
2.1.5 FRAMEWORK FOR ANALYSIS AND CLASSIFICATION 
Figure 6 attempts to show by means of a schematic diagram the above-mentioned 
research classifications with the analytical frameworks. (Figure 6 shows a section of 
Figure 3, Chapter 1 in more detail) . There is correspondence between the type of 
research and the focus of research . This can clearly be seen by examining the scientific 
disciplines which link to the respective research classifications. These cross-linkages 
have not been depicted in Figure 6 as this would result in a confusing array of eris-
crossing lines. 
Figure 6 shows how the general classes, namely, basic and applied research , relate to 
the two health research analyt:cal frameworks that are presented , namely, a health 
problem and a health system approach. These two approaches are concerned with the 
identification of specific health problems or health systems issues that need to be 
remedied, i.e., essentially applied research. 
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2.1.6 CRITERIA FOR RANKING 
Different analytical frameworks will generate different lists of research priorities. The 
application of the framework of Feachem et al. or any other perspective, merely generates 
long lists of health research neJds. Feacham et al. (1989) argued that prioritisation is 
essential and it is necessary to rank the list. Judgements in prioritisation involve a weighting 
of values. The technical methods used to assist decisions on priorities generally mask the 
underlying value judgements. Several values can be identified that can guide decision 
making. These usually include the following: effectiveness, efficiency, impact, equity, 
consumer satisfaction , capacity and sustainability. These can be broadly grouped as 
efficiency, equity and sustainability. Criteria provide the means whereby the health 
research needs can be ranked . The selected criteria become the expression of the 
weighting of the underlying values. 
A health problem approach focuses on the magnitude of the health problem as the 
fundamental criterion. However, there are different ways to measure this which range from 
objective quantification of mortality and morbidity through to the perceptions of 
stakeholders such as the community. A health research priority is established precisely 
when there are no cost-effective solutions to a health problem (Frenk 1995). Hence, 'a gap 
in knowledge' that necessitates further research is a criterion in its own right. 
An important criterion in the South African context is equity. Unless target groups such as 
marginalised or minority sectors of society are identified within a health problem approach , 
equity is generally neglected in this approach . When using a population focus for 
determining priorities in health research, the target group is generally selected through 
historical disadvantage. Equity is an underlying criterion in this approach . Janovsky and 
Cassels (1996) suggest that in the case of health systems research , there is a need to 
identify the importance of a topic. They recommend that if a topic cannot be judged in 
terms of impact on health status then it should be examined in relation to other policy 
objectives or values such as efficiency, equity in allocation, equity in outcome or consumer 
satisfaction. The resources required to undertake the research is an important criterion ; a 
vital resource relates to the research community and issues such as capacity, the 
researchers ' interests and the availability of funds. 
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The potential outcome of research is another criterion and can be assessed by the 
appropriateness of the methodology, how well the research will be conducted , cost 
effectiveness, the ethical acceptability of the research and the feasibil ity of the proposed 
intervention (Frenk 1995). 
A criterion that plays a role in prioritisation of health research is the time focus of the 
research . This includes the estimated time until the benefits of the research are realised 
and to what extent the research is aimed at the health problems of the future. Another way 
of looking at the time-related criteria for research priority setting is whether the research 
addresses long-, short- or medium-term health problems. 
Another important criterion for developing countries like South Africa is whether the focus 
of the research is on a pre- or post-transitional health problem (ENHR 1991 [a]) . In other 
words does the research focus on, for instance, the infectious diseases of the poor or does 
it focus on the health research demands of the more affluent sectors of the population . It 
is essential that a balance between the two foci be maintained. 
The American National Institutes of Health (NIH), lists five major criteria for the allocation 
of research funds: public health needs, the scientific quality of research, the probabil ity of 
success, the maintenance of a diverse portfolio and the maintenance of an adequate 
scientific infrastructure (Gross et al. 1999). 
2.1.7 COMBINING CRITERIA 
Somehow all selected criteria for health research prioritisation need to be taken into 
account to establish the most appropriate priority list for health research . There is a need 
to operationalise the criteria and define these in detail. "In practice it is easier to apply the 
criteria when they are in the form of specific questions" (Tan Torres 1997 P 35). Friedman 
(ENHR 1991 [a]) goes as far as proposing an explicit formula to combine selected criteria 
as a method of calculating the priority of the health problems. This quantitative approach 
remains untested. However, Varkevisser et al. (1991) have developed a rating scheme 
for prioritising health systems research which combines seven criteria with equal weights . 
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Tan Torres has suggested that a deliberate decision needs to be made as to whether equal 
weights for selected criteria are used (Tan Torres 1997). 
The criteria should , as far as is possible, be independent of each other in order to minimise 
the effect of 'double counting '. Examples of interrelated criteria are the magnitude and 
urgency of the problem or the interaction between magnitude and the expected impact of 
the intervention (ibid) . The application of certain criteria can yield conflicting results such 
as the criteria of equity and cost-effectiveness. Clear definitions of the criteria and 
delimitations should be agreed upon by decision-makers (ibid). 
Janovsky and Cassels (1996.) examine the idea of a common standard for assessing all 
health research priorities across all perspectives. They question whether different types of 
health-related research can be fitted into the same framework and whether decisions 
between competing demands can be made objectively. They conclude that it is not 
possible and recommend that a systematic approach within each area is needed and that 
the criteria for each may be different. 
2.1.8 STEPS USED BY THE AD HOC COMMITTEE FOR PRIORITISATION 
In 1994 the Ad Hoc Committee on Health Research Relating to a Future Intervention 
Options was established under the auspices of the World Health Organisation. It reviewed 
the global research priorities for developing countries building on the World Bank 
Development Report (World Development Report 1993). Equity was included in this 
exercise by targeting the needs of developing countries. 
The Ad Hoc Committee (Investing in Health Research and Development 1996) used both 
the health problem approach and the health systems approach in separate exercises. 
2.1.8.1 Health problem approach 
In the health problem approach the first step was to identify major health problems by 
calculating the scale of the problems using the innovative DALY measure. The DALY 
combines the burdens due to mortality, morbidity and injuries. The second step was to 
identify why the disease burden persists, whether it was the result of (a) lack of knowledge 
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about the disease and its determinants, (b) lack of tools , (c) failure to use existing tools 
efficiently or (d) some combination of these reasons. Using additional data on cost-
effectiveness and judgement of field experts on the proportion of the population receiving 
effective interventions, a rectangle representing a specific disease for a particular region 
or globally can be produced. The subdivisions within the rectangle break down the burden 
into different portions. These subdivisions are: 
• "what portion of the total burden of each disease or condition is now being 
averted ; 
• what could be averted now with better use of existing cost-effective interventions; 
• what could be averted now, but only with interventions that are not cost effective; 
and 
• what cannot be averted with existing interventions but require new ones" (ibid) . 
This analysis is depicted in Figure 7, below, with an example from the report of the Ad 
Hoc Committee, showing the burden that is avertable with existing interventions for 
tuberculosis (TB). "The analysis is intended to identify where the greatest needs lie and 
thereby guide assessment of the priorities for different types of research" (Investing in 
Health and Development. Report of the Ad Hoc Committee 1996 P 6). 
The procedure for this example can be summarised as follows: Step one identified TB 
as a major health problem. Step two involved analysing the reasons for its persistence 
under the three broad headings: (a) lack of knowledge of the disease or its causes (b) , 
lack of tools to prevent or treat it, and (c) failure to use existing tools effectively. As (a) 
the cause of TB and the predisposing factors for the disease are largely known, its large 
scale persistence must therefore lie either in (b) a lack of tools or (c) inefficient use of 
existing tools or both. 
Further analysis in terms of the subdivisions of the rectangle led to the conclusion that 
research and development efforts need to be divided between biomedical research to 
devise new interventions and operational research to make existing interventions more 
efficient. 
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FIGURE 7: Analysing the burden of tuberculosis to assess research needs 
Averted 
Effective coverage 
Burden avertable with existing interventions 
Unavertable with existing technology 
Avertable with improved efficiency 
56 million DAL Ys 
--------
Avertable with 
cost-ineffective 
intervention 
Note: The total DALY figure represents the number for this condition in 1990 plus an estimate of the 
number then averted through existing interventions 
Source: Investing in Health Research and Development. Report of the Ad Hoc Committee (1996) 
The above analysis is an integral part of step two of the Ad Hoc Committee system 
which is, identifying why the disease burden persists. The use of the rectangle is a way 
of analysing the burden of a health problem in terms of identifying research needs. This 
is also part of step two in the planning cycle, (Figure 5), which follows the situational 
analysis, i.e., to remedy the situation by determining priority health research . While this 
analysis cannot offer precise analysis of need, it indicates "a sense of the relative 
distribution of the effort required" (ibid P 6). 
Step three involves judging the adequacy of the knowledge base. This involves judgement 
on whether the research community has sufficient information to proceed with the 
development of new interventions or whether more strategic research is needed. Step four 
assesses the cost-effectiveness of the future interventions and whether the intervention 
can be developed soon for a reasonable outlay. Step five examines what has already been 
done about the problem, i.e. what resources had already been allocated to the problem 
and whether resources would had been better utilised elsewhere. Thus, in a stepwise 
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manner, the criteria of magnitude, knowledge gap and efficiency were incorporated into the 
prioritisation process. 
2.1.8.2 Health systems approach 
The Ad Hoc Committee recognised that the focus on specific health problems was not 
adequate to inform health policy. While specific policy or health system issues emerge in 
a health problem approach , the cross-cutting issues do not achieve the cumulative 
importance they may deserve. Research priorities in these areas were identified using a 
completely different process. Comprehensive review of both lay and expert consultation 
was used to identify research priorities for the demand and the supply side of the health 
system. 
It would appear that the Ad Hoc Committee made use of Janovsky and Cassels' (1996) 
suggested framework that incorporates three sets of factors . Firstly, there is a need to 
assess the perceived importance of the topic; this relates to the policy objectives of equity, 
efficiency or responsiveness to users. Secondly, even if the topic is considered to be 
important, it is necessary to determine whether the proposed research will advance the 
current state of knowledge. Thirdly, the research methods proposed should generate 
information that is useful to policy makers. Thus, in the health system approach, a stepwise 
process was used to combine equity, efficiency and knowledge gap and the acceptability 
of the intervention. 
2.2 CONCLUSION 
A myriad of the factors that impact on health and guide the choice of appropriate 
intervention decisions on evolving health problems is presented as important background 
for the process of setting research priorities. Recognition is given to the restricted focus 
on the methods, of prioritisation and not the full analysis of the policy process. 
In this chapter, two extreme methods for setting priorities, the rational and the incremental 
were identified. Realistic rational planning is recommended as a method of analysing 
priorities as it has aspects of both extremes, combining technical skills with a recognition 
of the political process. 
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From the literature, it was seen that there are basically two orientations for analysing health 
research , a health problem approach or a health system approach; both are important. 
Leading on from these approaches, two useful frameworks for analysing and classifying 
research were identified ; these in turn linked health research to scientific disciplines . The 
resulting classification provides a useful framework for organising health research . This 
incorporates the focus of research, identifying the purpose, as well as the type of research , 
which may be useful for describing resource allocation. 
No matter what approach is used to identify health research needs, there is a need for the 
identified health research priorities to be ranked. This part of the prioritisation process 
utilises various criteria which represent important underlying values. The step-wise system 
for prioritisation of the Ad Hoc Committee is presented . This system employs different 
approaches for priority setting for health problems and health systems. This dual approach 
is comprehensive and is valuable as it is a systematic and transparent exercise that can 
be replicated. 
However, it is important to note that the political process strongly influences what research 
is ultimately carried out. This political process, whilst alluded to throughout the analysis of 
priority setting, has not been discussed in detail. 
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CHAPTER 3 
MEASURING HEAL TH OUTCOMES 
"Can you do Addition?" the White Queen asked. 
"What's one and one and one and one and one and one and one and one and one and 
one?" 
"I don 't know," said Alice. "I lost count. " 
(Carroll, 1872) 
3.1 HEALTH STATUS 
Before going on to a detailed discussion of measurement of health outcomes, it is 
important to conceptualise what is being measured. Health status needs to be examined 
in more detail in order to emphasise the complexity of health outcome measures. 
Figure 8 is a simple model of health status showing it as being the result of health 
determinants and interventions. Health status is defined through these two factors 
individually and as a result of the interaction between them. Health outcome measures 
reflect various facets of health status. (Figure 8 is a schematic version of Figure 4 in 
Chapter 2.) 
FIGURE 8: The relationship between health status, determinants and interventions 
I HEAL TH DETERMINANTS 
I INTERVENTIONS 1-, ---------------.1 HEALTH STATUS 
Source: Lerer 1996 personal communication 
Health determinants can be labelled proximal (direct) or distal (indirect) . Smoking is an 
example of a proximal determinant; more distal determinants would be the social , 
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demographic and economic factors promoting tobacco use. "Distal determinants are mainly 
in the macro-economic, educational , environmental , demographic and health arenas" 
(Lerer et al. 1998 P 9) . "Distal determinants are considered to be the driving forces of 
health status" (ibid P 12) . "The effects of distal determinants are often , but not invariably, 
mediated through proximal determinants" (ibid P 9) . 
Proximal determinants are regarded as direct causes of changes in health status . Many 
proximal determinants of health status can be prevented "(through health education and 
promotion) and regulated (through fiscal and legislative measures)" (Lerer et al. 1998 
P 15). 
The relation between determinants and health status is largely indirect. It is modified by 
factors such as class, gender, education and socio-economic disparity" (Lerer et al. 1998 
P 18). 
3.2 MEASUREMENT 
It is important to consider measurement, per se, as there have been extensive advances 
in the development of summary health measures that have not been comprehensively 
documented. Furthermore, the summary measures of health are not strictly objective and 
therefore it is necessary to analyse the values and social preferences inherent in them. 
The DALY is a relatively new measure that has been used as a measure of global burden 
of disease and for global comparative assessments in the health sector (WDR 1993; 
Murray 1994). Furthermore, in terms of health and development, the DALY has been an 
adjunct tool in determining future research intervention options. (Investing in Health 
Research and Development. Report of the Ad Hoc Committee 1996). There has also been 
increasing utilisation by the WHO of summary measures to assess performance of health 
systems. An example of the latter is Disability Adjusted Life Expectancy (DALE), (The 
World Health Report 2000). 
Measurement is more than the simple act of counting and adding data. There are also no 
physical devices available to measure constructs in the social and behavioural science ... 
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According to the widely quoted WHO definition , health is defined in very broad terms. It is 
not seen to be simply the absence of disease but a state of well-being at all levels of 
human existence (Investing in Health Research and Development. Report of the Ad Hoc 
Committee 1996). 
Measures of health status must address the underlying issue of values. The notion of 
health versus illness or disability is a value judgement. Whatever is used for defining 
health , be it, biological , psychological , social or cultural criteria , "there are existing values 
that identify deviation from an acceptable state of being, reflecting peoples' deepest 
aspirations and fears" (Patrick and Erickson 1993 P 19). In order to measure health , this 
conceptual framework needs to be made operational. The measurement of health 
proceeds by assigning numbers to health states and manipulating these numbers. 
Indicators of health status define quantities that describe aspects of health . These 
indicators are considered to be either 'negative' or 'positive' measures. An example of the 
former is mortality and an example of the latter is life expectancy. Although the ultimate 
goal is to promote good health , the primary focus of most health measurements is disease 
or ill-health, because of the difficulties of measuring health. However, with the current 
emphasis in public health shifting to health promotion, more attention has been given to 
positive indicators such as social and mental well-being. 
The more usual measures of mortality and morbidity are inadequate for assessing people 
who are not ill but have some limited function which affects their everyday life. During the 
last few decades particularly, new health indicators or health outcome measures have been 
developed to assist in the analysis of the consequences of disease. The concept of 
morbidity has been extended to incorporate the personal and social consequences of 
diseases as well as quality of life measures. 
The various measures of health outcome will be presented from an historical perspective. 
In particular, the combined indicator of mortality and non-fatal outcomes, the DALY, will be 
examined in some detail and compared to other related measures. The intended uses of 
the measures, whether for assessment, comparison at regional or national level, or 
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planning will be discussed. The usefulness of the DALY to aid health research prioritisation 
will be highlighted. 
3.2.1 MEASURES OF MORTALITY 
The measurement of health status dates back to Babylonian times when mortality rates 
were used to assess the health status of the population . 
Life expectancy is an index of mortality. It can be estimated from a life table of the 
population and reflects both childhood and adult mortality. An expectation of life must 
always be related to people at a particular age. Life expectancy is usually the measure of 
the expectation of life at birth. 
A crude death rate is the number of deaths in a given time period divided by the population 
at risk. Adjusted rates are hypothetical summary rates constructed to permit fair 
comparisons between groups differing in some important characteristic, such as, age. ~ 
standardized rates are constructed by applying the rates for each age group to a standard 
population. 
Detailed rates for specific groups are needed to analyse epidemiological aspects of 
disease and population dynamics. For example, the infant mortality rate, the number of 
infant deaths in a year divided by the number of live births in the year is an important 
indicator. Child mortality - the probability of a child dying before the age of 5 - is also 
used as a proxy measure of the health status of the population. 
Measures of adult mortality, such as the 45Q15 are also important indicators of population 
health status. The 45Q 15 is the probability of a 15-year-old dying before the age of 60, and 
describes the level of premature adult mortality. The 35Q15, (the probability of a 15-year 
old dying before the age of 50), is an important indicator of young adult survival which is 
changing rapidly due to the AIDS epidemic. 
The concept of time lost to mortality, rather than death rates, was introduced in the late 
1940s (Dempsey 1947). Subsequently, there have been a wide variety of methods 
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proposed to measure years of life lost. Allied concepts include premature mortality and 
preventative mortality. An example of a measure that introduces a time dimension to the 
evaluation of health is Years of Potential Life Lost (YPLL) . Potential years of life lost are 
calculated by defining a limit to life and determining the years lost due to each death as the 
limit minus the age at death . The potential limit to life is an arbitrary figure ranging from 
about 60 to 85 years . YPLL takes account not only of the number of deaths from a disease 
but also the number of years that people might have continued to live on average 
compared with their counterparts (Public Health Status and Forecasts P 43) . 
3.2.2 MEASURES OF MORBIDITY AND NON-FATAL OUTCOMES 
Disease-specific measures of morbidity date from the nineteenth century. Two indicators 
of morbidity are incidence and prevalence. 
Incidence rates are the number of new disease cases over a period of time divided by the 
population estimate. Incidence rates are a direct indicator of the risk of a disease. 
Prevalence rates measure the number of people in a population who have a disease at a 
given point or period in time divided by the population estimate. Prevalence rates capture 
both incidence and duration of a disease. 
These indicators relate to the etiology of disease.s and recently, more attention has been 
given to the measurement of morbidity and non-fatal health outcomes and the associated 
quality of life. This shift is in part due to the preponderance of chronic diseases, particularly 
in the industrialised countries with aging populations. Developing a measure of disability 
is exceedingly difficult: One reason for this is that, unlike mortality, there are many 
dimensions to disability such as physical disabilities, pain, discomfort, emotional distress 
and loss of dignity (Morrow and Bryant 1995). 
Three important conceptual frameworks are used for non-fatal health outcomes (Goerdt 
et al. 1996). According to Murray (1994 P 10), these have developed in isolation as a result 
of "disciplinary focus , geographical and institutional locus and types of health systems." 
The different strands include: 
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1. The International Classification of Impairment, Disability and Handicaps (ICIDH) 
classifies three dimensions for the consequences of disease. Impairment is defined 
at the level of the organ system, disability is the impact on the performance of the 
individual while handicap includes the overall con-sequences which depend on the 
social environment. There are many valid criticisms levelled at the ICIDH. These 
include its inaccessibility and unnecessary complexity as well as the absence of a 
recommended assessment schedule. Furthermore, it has been recommended that 
it be updated (Katzenellenbogen 1991 ). A revised version of ICIDH-2 (pre-final) has 
emphasised health and health related domains. 
2. The health-related quality of life approach, (HRQL), was developed mainly in North 
America . The indicators are weighted aggregates of variables measuring physical , 
mental and social function . They include both objective and subjective measures 
of functional status and well-being. 
A range of instruments for measuring the incidence or prevalence of health states 
in the community have been developed in the HRQL field . These include generic 
instruments that provide a profile of health status relevant to quality of life (QOL) 
such as the WHOQOL (WHO 1993) and the EuroQol (EuroQol Group 1990). More 
recently, the Evidence Cluster of WHO has developed a tool which is being piloted. 
The theoretical bases for defining health and quality of life states are the theories 
of positive well-being and quality of life from psychology and functionalist theory 
from sociology and anthropology (Patrick and Erickson, 1993 P 60). 
3. An utilitarian framework underlies most of the work on health economics. In this 
theory, non-fatal health outcomes are important only to the extent to which they alter 
an individual's utility. Utility in economics is synonymous with the satisfaction of 
individual preferences. The focus is on the measurement of preferences rather than 
on the measurement of characteristics of health that individuals' value. The analysis 
of util ity includes measures such as PYLLs, DAL Ys or QAL Ys, which "explicitly 
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introduce one or more subjective parameters in order to value outcome" (Musgrove 
2000P110). 
3.3 SUMMARY MEASURES COMBINING MORTALITY AND NON-FATAL 
OUTCOMES 
Extensive research has been carried out to develop more general measures of non-fatal 
health outcomes that are commensurate with time lost due to premature mortality. Since 
Sullivan's (1971) proposal in the late 1960's of a composite index of health status that 
incorporates mortality and morbidity, there has been much debate on the value of these 
single indicators (Murray 1994). However, there are no comprehensive overviews of these 
measures. This section attempts to provide such . 
Composite measures of health are invaluable for comparing different health conditions and 
for monitoring health services and research. It is difficult to compare different health 
conditions directly as each has different ill-effects, with the resulting problem of comparing 
'like with true like' . As a result there has been a number of attempts to create composite 
measures which assign values to different combinations of health states such as, death, 
pain and disability. 
Early work on composite health status indicators was that of the Ghana Health Assessment 
Project Team (1981 ). This work was a first attempt to evaluate the burden of disease due 
to disability and premature mortality by cause for an entire population . The measure, 
healthy days of life Jost (YHLL) , was used with the assumption that days lost to death, 
being permanently disabled or temporarily disabled should be valued equally. This 
composite indicator combines morbidity and mortality to provide quantitative measures of 
losses from particular diseases and gains from particular interventions. 
3.3.1 QAL Y: QUALITY ADJUSTED LIFE YEAR 
Torrance et al. (1972) developed a measure in which health states between perfect 
health and death are weighted by the utility to the individual of time spent in each of these 
states. Zeckhauser and Shephard (1976) were the first to label such a measure of utility 
or preference-weighted time as QAL Ys. The term QAL Y refers to a time-based measure 
which includes life expectancy and non-fatal health outcomes where time spent with non-
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fatal outcomes is adjusted by a preference weight. QAL Y is a rubric for a family of such 
measures; there is no standard method for calculating QAL Ys. 
The QAL Y measures years of survival weighted for the quality of life , which people may 
be expected to have in the context of different states of illness. Attempts to quantify the 
quality of life have been conducted in some cases by experts and in others by 
communities (Barker and Green 1996). QAL Ys have been used extensively in cost-
effectiveness studies but have had limited use in describing the comparative burden of 
different conditions. 
3.3.2 DALY: DISABILITY ADJUSTED LIFE YEAR 
The 1993 World Bank Development Report and the Ad Hoc report ( 1996) make extensive 
use of the DALY as a composite measure of disease burden. William Foege (1994) sees 
the DALY as a major public health development of the past century. He states that the 
DALY concept has the potential to revolutionise the way in which we measure the impact 
of disease. The DALY combines years of healthy life lost from disability with those lost 
from premature death . DAL Ys were calculated for over one hundred specific diseases 
for eight demographic regions worldwide. 
The DALY is calculated by adding Years of Life Lost (YLL) and the Years Lived with 
Disability (YLD). The YLL is determined using the West model life-table to determine 
age- and sex-specific life expectancies. This is one of four key values or social 
preferences that are incorporated in the DALY. 
The YLD is calculated on the basis of the incidence and duration of conditions resulting 
in non-fatal outcomes and are weighted according to the severity of the disability of the 
sequelae. In this way, another explicit value is attached to the time lived with a disability 
to make it comparable to time lost due to premature mortality. 
In contrast to the Ghana study (1981 ), the DALY calculations for the measurement of 
disability use a standardised method for defining, measuring and weighting disability. 
Health professionals from around the world were asked to evaluate the disability for the 
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average individual with the condition described , taking into account the average social 
response or milieu and using the person trade-off methodology. Individuals were asked 
to choose between curing a certain number of individuals in one health state and another 
number in a different health state. The methodology elicits the point at which the 
individual is indifferent to the two choices being offered . At this point the outcomes are 
equivalent and a weight is derived (Murray 1994). Based on the results from the person 
trade-off protocol , the spectrum from perfect health (0) to death (1) was divided into six 
arbitrary classes. Highly consistent results were obtained from the various groups that 
participated for the disability severity weights for the 22 indicator conditions. Each class 
is exclusively defined by the range of disability weights and contains two or three indicator 
disorders, that act as benchmarks for the definition of each class . 
The third explicitly social preference incorporated in the DALY, is the value of time lived 
at different ages. This is shown in Figure 9, which depicts the age-weight function . The 
middle age group, 9-54 years, is weighted more than the extremes. 
FIGURE 9: Age-weight function 
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The fourth social value incorporated in the DALY relates to time preference and involves, 
the choice of a discount rate for future loss. Discounting implies a greater preference for 
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time lived now than at some time in the future . This is particularly important in the context 
of cost-effectiveness assessments where future costs are discounted . 
The general underlying concepts and specific values as well as the justification of certain 
assumptions used in the formulation of this measure are made explicit. 
3.3.3 Heal Y: HEAL THY LIFE YEARS 
Another new composite measure is the Healthy Life Years (Heal Y) , which is a measure 
of healthy life-years lost, reformulated from the Ghana Health Assessment study data . 
Details are given in Appendix 2. 
It is defined as "a composite measure that combines the amount of healthy life lost due 
to morbidity with that attributable to premature mortality" (Hyder et al. 1998 P 196). The 
defining characteristic of the Healy is that it is based on the incidence pattern within the 
conceptual framework of the natural history of disease rather than the juxtaposition of 
current mortality and the current incidence patterns. 
3.3.4 DFLE: DISABILITY FREE LIFE EXPECTANCY 
The principle of the calculation of Disability-Free Life Expectancy was postulated in the 
early 1960s. However, the first method of calculation of such a measure was proposed 
by Sullivan in 1971 . The institutionalisation rate (generally from a recent census) and the 
prevalence of various states of functional disability (from national health or disability 
surveys) are incorporated with the years lived at various ages by the population of a life 
tab le. The period life expectancy for the modified table is calculated in the traditional 
manner yielding the value of Disability-Free Life Expectancy. The advantage of Sullivan's 
method of calculating health expectancy is that mortality and disability data are treated 
separately and the data necessary for the calculations are available. The problem with 
this method is that it approximates the period prevalence by the observed prevalence 
within the population; it is not really a period indicator (Goerdt et al. 1996). 
3.3.5 DALE: DISABILITY ADJUSTED LIFE EXPECTANCY 
The DALE is calculated using a weighted number of years lived with disability added to 
the years of healthy life lived at a specific age. 
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3.4 COMPARISONS OF COMPOSITE MEASURES 
3.4.1 QAL Y AND DALY 
The QAL Y can be considered to be a precursor of the DALY. The DALY like the QAL Y 
allows both fatal and non-fatal outcomes to be combined in a single indicator. However, 
the QAL Y is a measure of health rather than ill-health . 
Marrow and Bryant (1995) point out that with the QAL Y, the focus is on assessing 
individual preference for different non-fatal health outcomes that might result from a 
specific intervention and that the DALY was developed primarily to compare relative 
burdens among different diseases and among different populations. 
The DALY is considered to be a simpler and more 'objective' measure than the QAL Y as 
it is concerned with the severity of disability rather than the quality of life. 
3.4.2 Heal Y AND DALY 
The Heal Y differs from the DALY in that no differential is given to the value of life 
according to the age at which life is lived. Another difference is that discounting is 
integrated into the DALY formula, whereas with the Heal Y, discounting is done 
separately. 
The major purpose of the Heal Y formulation is the assessment of the effects of health 
interventions and not attributing loss to specific diseases. This is facilitated by the Heal Y 
formulation being based on life lost to disability and death for all disease with onset in a 
given year. The effectiveness of interventions are considered on the basis of current 
incidence patterns. For the DALY measure, mortality and disability are considered for all 
deaths in the current year regardless of when the onset of diseases occurred. 
3.4.3 DALY AND DALE 
The DALY is a measure of the health gap whereas the DALE is a summary measure of 
health . The health gap is the difference between the actual health of a population and 
some reference status. DAL Ys are preferable to the DALE, the life expectancy in 
different classes of disability when the burden of non-fatal outcomes and premature 
mortality needs to be broken down into the burden attributable to various diseases, 
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injuries or exposures. This situation is analogous to cause specific death rates versus the 
relative utility of life-expectancy (Murray and Lopez 1997[b] P 1352). 
3.4.4 DFLE AND DALE 
Disability-Free Life Expectancy, (DFLE) and Disability-adjusted life-expectancy, (DALE) , 
are two measures of health expectancy. DFLE is a calculation of expected length of life 
without disability. The DALE is calculated in the same way as the DFLE at birth , with the 
DFLE, the number of years lived at a specific age is obtained from a life table. The DFLE 
measure attributes zero weights to estimates of life expectancy in different health states. 
DALE calculations are estimates of life expectancy for different health states adjusted for 
the GBD disability severity weights (Life Expectancy minus the DALE equals the severity-
adjusted expectation of disability). Both are useful ways to summarise the health status 
of a population. Further examples include, Impairment Free Life Expectancy (IFLE) and 
Handicap Free Life Expectancy (HFLE) and are considered to be positive health 
indicators. 
International comparisons of DFLE and other health expectancy measures have been 
hampered by differences in calculation and definition. However, the new WHO Report 
2000 which incorporates estimates of DALE for each country is likely to create a standard 
approach that will overcome this problem (WHO 2000). 
3.5 COMPARISON OF DALE VERSUS LIFE EXPECTANCY 
The World Health Report 2000 has focussed on evaluating the performance of health 
systems. Data from this report for DALEs and Life Expectancy for males and females for 
the 191 WHO Member States was analysed, using regression analysis. DALEs were 
regressed on Life Expectancy. The results, as expected, are very highly correlated. This 
can clearly be seen in Figures 1 O and 11 . 
Based on the regression model, the DALE is on average 10 years less than the Life 
Expectancy. 
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3.6 COMPARISON OF DALY VERSUS MORTALITY 
Roughly two thirds of the global burden of disease measured by DAL Ys , is due to 
premature death and one third is due to disability (Jamison et al. 1995). The morbidity 
component of the DALY is generally more difficult to quantify than mortality due to the 
number of parameters and limited data. Hence it is important to understand what gets 
added by the morbidity component, (YLD), of the DALY over and above the mortality 
component, (YLL). The use of the DALY as opposed to mortality data only for the 
setting of health priorities is explored in the following section; this is integral to the 
question as to whether one needs dally with the DALY. 
Some medical classifications have only a mortality component, for example suicide, 
whereas others have negligible excess mortality and a large non-fatal component such 
as some psychological disorders. A whole spectrum of differing mortality/morbidity ratios 
for different diseases and injuries lie between these two extremes. The relationship 
between mortality and non-fatal burden is investigated by means of linear regression 
analysis. In addition , in order to examine mortality and the DALY, YLLs were expressed 
as a percentage of DAL Ys for all diseases for SSA that were included in the regression 
analysis. 
3.6.1 DATA 
Estimates from the Global Burden of Disease study for Sub Saharan Africa for DALY and 
YLD values for each disease are used (Murray and Lopez (1994) . The YLL values could 
readily be obtained by subtraction from the reported DAL Ys. Table 3 below shows the 14 
diseases or injuries that were excluded from the analysis as they had either a negligible 
mortality component or a negligible non-fatal component. These conditions clearly do not 
have a relationship between the YLDs and YLLs. 
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Table 3: Sub-Saharan African diseases and injuries which have either YLDs or 
YLLslessthan1000 
DISEASE OR INJURY 
(ICD 9 CODE) 
Conditions with mortality but little 
morbidity or disability 
1 Hypertension complicating regnancy, 
childbirth and puerperium (642 MINUS 
642,4-642,6) 
2 Other Neoplasm (210-239) 
3 Skin disease (680-709) 
4 Drowning (E910) 
5 Self-inflicted (E950-950) 
Conditions with morbidity and disability 
but little mortality ,, ,,_ : .. ,, 
1 Trachoma (076) 
2 Major affective disorder(------) 
3 Post traumatic stress disorder(-----) 
4 Glaucoma related blindness (365) 
5 Cataract related blindness (715) 
6 Osteoarthritis (521.0) 
7 Dental carries (523) 
8 Periodontal disease (520) 
9 Edentulism 
(Source: Murray and Lopez 1994) 
I Communicable, maternal and perinatal 
I/ Noncommunicable 
Ill Injuries 
- indicates less than 1000 YLDs or YLLs 
3.6.2 METHODS 
BOD YLD YLL 
Category (1000) (1000) 
I - 204 
II - 453 
II - 113 
II I - 1554 
II I - 1686 
. 
I 901 -
II 1647 -
II 505 -
II 171 -
II 1130 -
II 223 -
II 436 -
II 417 -
II 41 -
The four graphs and the statistics were obtained using the Advanced Regression 
programme of the spreadsheet Quattro Pro (Version 6 1997). The graphs have the YLD 
as the dependent variable and the YLL as the independent variable. Both measures have 
been transformed using a natural logarithmic scale of the measure plus one, so as to 
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have a more meaningful spread of the data that was more normally distributed. This was 
necessary as there were some outlying values. Linear regression lines were fitted with 
log (YLD +1) as a function of log(YLL +1) for All diseases and the three sub-groups of: 
Communicable and Maternal , Non-Communicable and Injuries. These correspond 
Figures 12, 13, 14 and 15 respectively. There are 68 observations with 20 observations 
for Communicable and Maternal, 41 observations for Non-Communicable diseases and 
7 observations for Injuries. The correlation coefficient (R2) was used to describe the 
extent of the relationship between the transformed DALY and YLL. The significance of 
the correlation is assessed using the p-value. 
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FIGURE 12: Graph of years lived with disability against years of life lost: 
All Diseases 
1 1 
9 -
-
1 
~ 
+ 7 
""C 
>- 5 
-C) • -• 
0 
3 
1 
1 3 
all diseases 
SSA 
• 
• • • • • •• 
• 
• 
•• 
• 
• 
•• • 
••• I • 
•• 
• •• • • 
• 
5 7 
log(yll + 1) 
' .. 
• 
• • 
9 11 
R2 = 0.2409 
p < 0.0001 
FIGURE 13: Graph of years lived with disability against years of life lost: 
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FIGURE 14: Graph of years lived with disability against years of life lost: 
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FIGURE 15: Graph of years lived with disability against years of life lost: 
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3.6.3 RESULTS 
For the DALY versus YLLs, for All Diseases , the correlation for YLDs regressed on YLLs 
is, R2 = 0,2409. The correlation is highest for Communicable Diseases with R2 = 0,2554. 
The lowest correlation , R2 = 0,0975, is for for Non-Communicable diseases. The 
correlation is 0,2099 for Injuries. The probability values (p values) , range from p < 0,0001 
for All Diseases , to p = 0,3012 for Injuries. At the chosen probability level (95%) , there 
are 3 statistically significant results, i.e. they cannot be attributed to chance. The 
probability value for Injuries is not less than 0.05. It should also be noted that Injuries is 
the smallest sub-group, with only 7 values. 
However there is considerable variation and the average percentage value for YLL/DAL Y 
is 63, 1 %, mortality accounts for only 1,8% of the total burden for affective disorders while 
it accounts for 98, 1 %, for poisoning. While the diseases and injuries at both the 
extremes of the distribution of the YLL/DAL Y percentages, can be reasonably well 
identified , there is a wide range of values which cannot be easily identified with accurate 
predictions of the corresponding values. 
These results suggest that mortality cannot be used to predict morbidity. Hence, the 
morbidity or non-fatal component would be most a useful additional health outcome 
measure especially for Non-Communicable diseases. 
Although mortality is an important component for examining the burden of disease, 
morbidity cannot be ignored as it constitutes a relatively large portion of the burden of 
disease. Based on the calculation, on average up to 36% of the total burden can be 
attributed to morbidity. 
3.7 CONCLUSION 
The above analyses show that it is important to measure non-fatal health outcomes when 
considering burden of disease or health gap, as they constitute a large proportion of the 
burden of disease. 
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For the comparison of the DALE versus Life Expectancy, both correlation values 
approach unity, which represents perfect correlation . Thus, in the case of an overall 
summary of health , it would appear that life expectancy could be used as a proxy for 
DALE. 
In the case of prioritis ing health research through the identification of health problems, 
it is important to analyse the health gap. It is therefore clear that it is important to take 
non-fatal outcomes into account and that mortality is not an adequate proxy measure. 
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CHAPTER4 
THE DALY AND SETTING PRIORITIES FOR HEAL TH RESEARCH 
4.1 THE DALY AS A MEASURE FOR SETTING PRIORITIES 
The DALY as a measure of the health gap can be utilised in priority setting for research . 
However, since its development there have been many criticisms of the DALY. These 
criticisms relate to techn ical issues such as those concerning the quality of data used to 
calculate DAL Ys and more subjective or conceptual issues such as age and disability 
weights and discounting. According to Bobadilla (1996), the former can be remedied by 
relatively minor modifications to the original formula. He suggested that the conceptual 
criticisms can only be addressed once there has been more research on social 
preferences. 
In particular, the DALY Review Group of the WHO's Advisory Committee on Health 
Research (ACHR) (1995/96) stated that the DALY in its present stage of development does 
not solve the problem of prioritisation and resource allocation. Notwithstanding the fact that 
the head of the WHO has endorsed the DALY (Brundtland 1999), an examination of the 
criticisms levelled by the ACHR and others, as well as the counter-criticisms, will help 
assess the DALY as a measure of ill-health and a tool for setting priorities. 
4.2 TECHNICAL ISSUES WITH THE DALY 
4.2.1 POOR QUALITY DAT A 
The data demands to estimate the DALY are extensive. However, the data required for the 
calculation per disease by age and sex is not always available. Even if reliable morbidity 
information on the incidence and prevalence of disease and injury are available, it is 
possible that data on the likelihood of sequelae and their severity and duration are not 
available. For the GBD study the best estimates of epidemiological indicators which include 
incidence, remission rates , case-fatality rates and the general mortality rate were obtained . 
This was facilitated by the use of a computer programme called DISMOD (Disease model) 
to assess the consistency of the data. 
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The review of the ACHR (1995/96) refers to the poor quality data utilised for the DALY 
formulations . The review points out that a substantial proportion of the data used in the 
GBD study has been generated by modelling or guesswork. 
The problem is exacerbated for the SSA region where the estimates are considered to be 
based on an extrapolation from the 1 % of the Sub-Saharan population covered by vital 
registration in South Africa . Cooper et al. (1998) asserts that the estimates for SSA do not 
help define the burden of disease for that region and cannot be compared with developed 
countries . 
Murray and Lopez (1997[a]) respond to the problem of poor health information by pointing 
out that the use of the DALY to measure burden of disease indicates the strengths and 
weaknesses of existing health information systems. Furthermore, the GBD study makes 
use of DISMOD to derive internally consistent estimates of mortality, incidence and 
prevalence measures from the available epidemiological data. Through this process it is 
possible to identify information gaps and inconsistencies. lit is argued that since decisions 
need to be made, it is advisable to attempt to make the best use of available data by 
developing coherent estimates. 
4.2.2 INCIDENCE VERSUS PREVALENCE 
As time has been chosen as the unit of measure, the burden of disease could be either an 
incidence- or prevalence-based indicator. Murray (1994 P 6) , gives three reasons why an 
incidence perspective was chosen: 
1. The method of calculating time lived with disabilities is more consistent with the 
method for calculating time lost due to premature mortality. 
2. An incidence perspective is more sensitive to current epidemiological trends and will 
reflect the impact of health interventions more rapidly. 
3. Measuring the incidence or deriving it from prevalence data and information on 
case-fatality and remission rates imposes a level of internal consistency and 
discipline, which would be missing with the uncritical use of prevalence the data. 
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It is , however, important to be aware of the consequences of this choice. For instance, the 
DALY measure discriminates against currently disabled people as those previously 
disabled will not be included in the DALY calculations (Legge lecture UWC 26/1/96). 
Furthermore, the choice of incidence data favours distinct rather than diffuse or chronic 
conditions (DAL Ys and Reproductive Health 1999). 
4.2.3 PROBLEMS WITH COMPOSITE MEASURES 
The ACHR states that another difficulty with the DALY is the combination of unlike 
elements, namely death and disability. Death and disability are on the same continuum 
linked by time. Anand and Hanson (1996) argue that one simply cannot have the two 
events on the same scale as they are incommensurable. Anand and Hanson (1997) state 
that with the DALY scale, death differs from disability merely by reducing human function 
to zero and Paalman et al. (1998) point out that there may be states worse than death. 
In addition, by keeping disability and death data separate, the Review Group contends that 
it is easier to formulate more specific policies in the different countries. This would prevent 
the inevitably inexact estimates of disability from corrupting mortality data. 
As far as the criticism that the separation of disability and death would make it easier to 
formulate specific policies for different countries, Murray and Lopez (1997[a]) pointed out 
that it is not possible to estimate the DALY without separate calculations for disability and 
mortality, thus making this information available for policy formulation. 
4.2.4 VALIDATION 
Another criticism which relates to technical issues with the DALY concerns the validation 
of the DALY as an indicator of health status. According to Sayers and Fliedner (1997), this 
validation process involves ascertaining that the behaviour of the indicator in response to 
random error and systematic bias in the raw data is acceptable. They contend that 
sensitivity analyses by Murray and Lopez (1997[a]) contributes nothing to validating the 
indicator. 
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4.3 CONCEPTUAL ISSUES WITH THE DALY 
The general underlying concepts and specific values as well as the justification of certain 
assumptions used in the formulation of the DALY measure have been made explicit. Much 
of the criticism of the DALY has focussed on the social preferences or values included in 
the DALY. These include the unequal age weights , the discounting of future health years 
as well as the disability weights. 
4.3.1 THE DALY AS A UNIT OF MEASUREMENT: VALUES 
It is necessary to examine the underlying values of the DALY as well as whose values they 
represent. Anand and Hanson (1997) identify at least four distinct groups whose values are 
incorporated in the DALY used in the GBD exercise: 
1. The social planner who specifies the burden of disease exercise and the DALY function 
used to measure it. 
2. Various unspecified individuals for the age weighting function. 
3. The weights for the six disability classes were chosen by a group of independent 
experts and the criteria used to establish the weights were not made clear (Anand and 
Hanson 1997). 
4. The discount rate used is determined by the authors of the World Bank Report (Murray 
1994) and is set at 3%. This is consistent with the long-term yield on investments. 
Anand and Hanson (1997) argue that yield on investment has little to do with 
discounting health outcomes. 
The DALY measure of ill-health has a narrow focus as the quantity of ill-health experienced 
by individuals is represented through functional limitation and premature death only. Pain 
and suffering or reduction in well-being are not included in the DALY. Consequently, the 
DALY renders caring as discretionary and ineffective (Legge lecture, University of the 
Western Cape (UWC) 26/1/96) . Legge argues that caring activities which express the 
compassion within a health system stand at risk of being discounted by policies based on 
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the assumption that value for money is defined solely in terms of cure or prevention (Legge 
1993). 
4.3.2 SOCIAL VALUES 
4.3.2.1 Age-weighting 
According to Musgrove (2000), age-weighting is the most controversial of the subjective 
parameters used in the calculation of DAL Ys. Murray (1996[a]) justifies the chosen age 
weights on the basis that several studies have shown a preference for saving young adult 
lives over those of young children or elderly people. 
If viewed from a human capital framework, age-weighting might be justified in terms of 
differential productivity at different stages of life (Anand and Hanson 1997). However, 
Murray (1994 ) argues that he has not used a human capital framework as productivity 
weights do not adequately reflect human welfare. According to him, the productivity weights 
are not applied in a consistent manner and other human attributes linked to productivity 
such as education are not included in the weighting of time. Age-weights are justified in 
terms of social preferences. The social value of the middle-age groups is considered to 
be greater due to the responsibility for their dependants. 
Murray can be perceived as being inconsistent in that he does not use productivity weights 
in the development of the DALY because of their 'obvious inequality' , yet he appears to 
invoke what is essentially an economic cost-benefit argument to defend social time 
preference. However, Musgrove (2000) defends Murray by arguing that there is no 
inconsistency in rejecting an economic measure and then using age-weights that take into 
account the emotional loss of an individual's death to other people. 
Paalman et al. (1998) contend that such values would be impossible to generalise to one 
functional formula and would depend on context-specific conceptions of human value. 
Criticisms of the age-weighting function are not straight forward due to the confounding 
of age and disability that occurs with the DALY function . Barendregt et al. (1996) show that 
when comparing age-weighted and unweighted age-specific life expectancies, the age 
70 
range which becomes more important due to weighting is not 9-54 years but 0-27 years . 
This happens as expected years of life lost is an age-weighting system in itself, 
emphasising the young . The discounting of future years partly redresses the shift toward 
younger ages as discounting mostly affects life years lived at a higher age. 
Murray and Lopez ( 1996[b]) in their response to criticisms of the incremental effect of age-
weighting on YLLs, YLDs and DAL Ys agree with the findings of Barendregt et al. (1996) 
but contend, however, that the largest incremental change is closer to age 10 years . Their 
findings confirm the basic observation about YLL - that the interaction of duration of life 
lost, age-weighting , and discounting leads to a maximum YLL for a death during 
adolescence. Murray and Lopez (1996[b]) go on to criticise Barendregt et al. (1996) for 
concluding that their observations forYLL also applies to YLD. Murray and Lopez (1996[b]) 
state that this conclusion must be qualified, as the incremental effect of age-weighting will 
depend on the duration of disability. Barendregt et al. (1996) concede that given the rather 
small impact of the age-weight function on the specific life expectancies, their findings are 
not likely to upset the results of the GBD study. 
Furthermore, Murray and Lopez (1996[b]) argue that one can debate the actual values 
incorporated into the DALY but that once each of the values has been chosen one should 
accept the consequences of the combination of these values in calculations. 
4.3.2.2 Discounting 
The discounting of health benefits is controversial. Bowie et al. (1997) lists three reasons 
why individuals are likely to value future health benefits less than present benefits, so 
making discounting important: 
1. impatience or myopia - there is generally a preference for benefits now rather than in 
the future, 
2. uncertainty that one may not be capable of receiving future benefits and 
3. diminished marginal utility - one is likely to value additional units of benefits 
progressively less. 
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Anand and Hanson (1997) state that as with the case of age-weighting , a consistent 
defence of discounting could be provided if the human capital approach to valuing life were 
adopted . However, Murray rejects this framework. 
One consequence of discounting life years is that "future generations become virtually 
valueless" (ibid P 91) and that prevention is devalued as costs are incurred now with 
benefits only years later. On the other hand, if costs are discounted and benefits are not 
similarly discounted then it follows that it will always seem to be more cost-effective to defer 
treatment. Discounting the health benefits as well as the costs avoids the so-called time 
paradox. 
A further issue is whether both benefits and costs should be discounted at the same rate. 
Bowie et al. (1997) concludes the choice of discount rate is a policy issue and not just a 
technical question. It is interesting to note that the discount rate is more sensitive than age-
weighting. According to Barendregt et al. (1996) , the impact of discounting, even at the low 
value of 3%, as used in the GBD, is much larger than the age-weighting. 
4.3.2.3 Disability Weights 
Paalman et al. (1998) highlights a common criticism concerning the definition of the 
disability weights. They argue that there is a lack of transparency with the process whereby 
disability weights were established and apportioned among the different conditions in the 
DALY calculations. In addition, there are different dimensions used in defining the disability 
classes. The ability to pursue certain activities is used in some categories and the need for 
assistance used in others. These dimensions are not mutually exclusive. In order to be 
consistent all categories should have the same dimensions (Paalman et al. 1998). 
Also, as the duration and the severity of a disability are separated in the calculation of the 
DALY, their interaction is not captured. For example, the difference in utility loss for an 
individual due to temporary or permanent functional impairment is not taken into account. 
One is not able to distinguish between an individual with a certain disability weighting 
lasting ten years or ten individuals having the same disability weighting with the duration 
of one year each (ibid) . 
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Furthermore, Paalman et al. (ibid) contend that the disability weightings do not make 
allowance for conditions worse than death . Musgrove (2000) replies to this criticism by 
saying that these conditions are so rare and often short-lived so as to make little 
contribution to the overall burden of disease. 
DALY disability weights are at present determined by a panel of experts. The participants 
in a study on rural Cambodian women recommended that more open , transparent and 
inclusive processes be used to develop disability weights particularly for the application of 
the DALY at local level (DAL Ys and Reproductive Health 1999). This serves as an example 
of how marginalised sub-populations can be included in health policy formulation . So if the 
DALY is to be used at the more local level for setting national or sub-national health 
priorities, then not only epidemiological experts should be consulted , but input from those 
suffering from a condition, their family, health care providers and the general public should 
also be considered (ibid). This partly answers the criticism that with the DALY the burden 
which falls on households and communities is not included. On the other hand , if the DALY 
is to be used primarily to generate global level assessments of the overall burden, the use 
of panels of experts, representative of different regions and specialisations is acceptable. 
The recently conducted Netherlands (Meise et al. 2000) and Australian (Mathers et al. 
1999) burden of disease studies have overcome the problem with the measurement of the 
disability component of the DALY by using empirical data to link health status with 
diseases. This addresses the issue of the definition of disability weights, at least at the 
country-specific level. 
4.4 CO-MORBIDITY 
Multi-pathology refers to the simultaneous co-existence of more than one disease in a 
given individual. Each condition with its disability weight could result in these weights 
adding up to more than one for a given individual. This suggests that co-morbidity is not 
permissible in DALY formulations (DAL Ys and Reproductive Health , WHO 1999). 
Murray and Lopez (1997[a]) contend that the criticism that the multi-factorial nature of 
mortality and morbidity cannot be captured by the DALY is contentious. Diabetes mellitus 
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(OM) is given as an example to show that this has been done for some factors. Fi rstly, they 
estimated the burden of premature mortality and disability attributed directly to OM. Then 
they examined the total burden attributable to OM considering it as a risk factor for other 
conditions. 
Sayers and Fliedner (1997) point out that multi-pathology is not the same as multi-
causality. The latter refers to multiple risk factors involved in the occurrence of various 
individual diseases. Although multiple risk factors are undoubtedly involved in the 
occurrence of various individual diseases, the simultaneous co-existence of more than one 
disease in an individual is quite a different issue. The DALY does not take this into account. 
In effect, ir,L rventions are based on the underlying hypothesis of a single disease. 
Risk factors are those variables that can significantly increase an individual's risk of 
developing the disease. The risk factors in the GBD are: tobacco use, unsafe sex, mal-
nutrition, excessive alcohol intake, hypertension, physical inactivity, illicit drugs, air pollution 
and poor water supply, sanitation and personal and domestic hygiene practices. However, 
there may be equally important long-standing socio-economic factors such as poverty, 
inadequate housing and poor education. In addition, positive situations are not considered; 
such as a person being better able to cope with a disease or disability because of good 
social support, or perhaps the person is psychologically better able to deal with the illness. 
These long-standing factors are just as important as the other risk factors. The DALY is 
limited to the immediate determinants of disease or disability (ACHR 1995). 
Although risk factors for disease receive attention in the GBD study, Murray (1994) 
acknowledges that co-morbidity requires further research. Murray and Lopez ( 1997[b]) also 
specifically note that there is a need to examine dependent and independent co-morbidity. 
4.5 USE OF THE DALY FOR SETTING HEAL TH RESEARCH PRIORITIES 
The ACHR Review Group (1996 P 334) in their DALY critique strongly discounts the value 
of the DALY for setting research priorities as the following have not been adequately 
demonstrated: 
1. verification of the methodology (that it does what it purports to do) 
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2. validation of the underlying concept (i .e. that the DALY provides a valid basis for 
decision making) 
3. assessment of its util ity in practice (in comparison with other methodologies) 
The ACHR Review Group (ibid) has argued that the DALY methodology has not been 
validated and therefore it is not useful for health resource allocation. Murray and Lopez 
(1997[a]) answer this criticism by making three main points : 
1. The mathematical formulation of the DALY has been thoroughly reviewed with no 
objections. 
2. In order to counter the criticism that the social values incorporated into the DALY have 
not been validated, Murray and Lopez (ibid) conducted sensitivity analyses. These 
measured how results are affected by alternative values for the discount rates and age-
weights. DAL Ys were calculated with a zero discount rate and uniform age-weights 
versus DAL Ys calculated with a 3% discount rate and non-uniform age-weights. 
Changing these important social preferences has little effect on the rank order of 
conditions. Sensitivity analysis is used in determining how much the result changes as 
a function of systematically varying one or more of the variables (Morrow and Bryant 
1995). Anand and Hanson (1997) contend that although much has been made of the 
existence of sensitivity analyses concerning unequal age-weights , discount rates and 
disability class-weights, insensitivity to parameter changes can hardly validate a 
formula. 
Anand and Hanson (ibid) further suggest that there is some evidence to support the 
possibility that individual diseases are sensitive in compensating directions resulting in 
a relative lack of overall sensitivity. 
3. Finally, the Review Group (1996) argues that the epidemiological parameters 
(incidence, duration, prevalence and death) for each condition has not been validated . 
Murray and Lopez (1997[a]) make the point that uncertainty associated with 
epidemiological parameters has nothing to do with the validity of the DALY as a health 
outcome measures but has much to do with the validity of the results of the GBD study. 
They acknowledge that there is a need to improve data in order to narrow the range of 
uncertainty for estimates. 
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4.6 ISSUES OF EQUITY 
According to Morrow and Bryant (1995) the WDR refers to the importance of equity and the 
principles and methods it espouses are equity-oriented . The report clearly states that the 
DALY approach would guide allocations towards the greatest burden of disease and the 
most cost-effective interventions. Generally speaking that guidance will be toward those 
in greatest need . According to Paalman et al. (1998 P 24) , "the fact that the most efficient 
interventions identified in the WDR tend to specifically benefit the poor is more a result of 
coincidence than principle." 
Anand and Hanson (1996) elucidate that the very essence of public health is concern for 
equity which requires giving priority to the claims of disadvantaged people, not diseases. 
Murray (1994) argues that in terms of equity it is necessary to compare "like with like" and 
not to value death at a given age more in a high life expectancy country than in a low one. 
Murray and Lopez (1997 [a]) also defend the egalitarian framework on which the DAL Ys 
have been developed, stating that there is an ethical dimension of all health outcome 
measures. The DALY methodology explicitly states the underlying assumptions which may 
not be the case for other measures. "The normative aspects of a health indicator become 
evident when the measure is used as an aid to allocating health sector resources" (Murray 
and Lopez 1997[a] P 378). Furthermore, use of the DALY fosters constructive debate on 
the social choices that must be made to inform health resource allocation. 
Janovsky and Cassels (1996) counters this by saying that the acknowledgement of 
assumptions does not negate the fact that they have been made. According to Anand and 
Hanson (1996) proponents of the DALY do not distinguish between the exercises of 
measuring the burden of disease and of allocating resources. The appropriate information 
sets for the two exercises are quite different. The DALY is used for the exercise of 
measuring the burden of disease and for resource allocation. However, the latter has 
ethical implications. 
The ethical dimensions relate to the allocation of resources among individuals. Anand and 
Hanson (ibid P 688) pose the question: "What of those who are different along dimensions 
not included in the DALY information set?" In this regard the DALY fails to make 
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distinctions along dimensions such as income and socio-economic status which are 
important for allocating resources. "It is not ethical to treat similarly people of the same sex 
and disability status who differ in critical characteristics such as wealth or access to publicly 
provided services" (Anand and Hanson (ibid) P 701 ). According to them , the age-weighting 
and discounting schemes of the DALY have implications for resource allocation . 
When allocating resources within the health system, the principles of cost-effectiveness 
and equity can result in conflicting recommendations. An example is the provision of health-
care for remote and deprived populations in order to improve equity as opposed to 
providing care to more accessible populations which may be more cost-effective. Morrow 
and Bryant (1995) suggest that this conflict may be resolved by attributing infra-structural 
costs not only to the health sector. In addition, the gains in healthy life years will be greater 
in the under-served population than in those populations that have access to services. 
4.7 GENDER 
A critique of the DALY from a gender perspective clearly illustrates the impact of all the 
above-mentioned concerns. The critique is presented in terms of the previously discussed 
issues. In favour of DALY methodology when dealing with women's health and reproductive 
health, it is pointed out that the DALY is an advance on other quantification methods such 
as mortality indicators (DAL Ys and Reproductive Health WHO 1999). This is illustrated by 
the following example. For 1990 the average mortality rate due to pregnancy-related 
causes is 0,36% (585 000 cases) while the total figure for pregnancy-related complications 
is 12,5% (20 million cases), (DALYs and Reproductive Health 1998[b] P 4). These 
mortality estimates do not reflect the extent of ill-health associated with pregnancy as DALY 
calculations from the World Development Report estimate that reproductive ill-health 
accounts for 36% of the total disease burden among women of reproductive age (15-44 
years) in developing countries compared to only 12% for men. If perinatal causes are 
added , some 13,5% of the total DAL Ys lost can be ascribed to reproductive ill-health (all 
ages and both sexes combined) (DALYs and Reproductive Health 1998[a] P 1). Although 
the DALY served to highlight reproductive health issues it also has its shortcomings in this 
arena. Many of the criticisms are the same as those generally levelled at the DALY. 
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4.7.1 CONCEPTUAL ISSUES WITH REGARD TO GENDER 
One specific example which relates to value judgements inherent in the DALY concerns 
the inability of the DALY methodology to take into account the burden of ill-heath 
associated with stillbirths. Stillbirths are an adverse outcome of pregnancy linked to 
inadequate health care during pregnancy and delivery and should be part of the burden of 
reproductive ill-health (DAL Ys and Reproductive health 1998[c] P 3). "By definition no 
individual can have any expectation of healthy life until the moment of live birth . Stillbirths 
are therefore not counted as adverse outcomes either for perinatal conditions or for the 
mother unless the stillbirth is associated with a maternal condition such as obstructed 
labour" (DAL Ys and Reproductive Health 1999 P 10). There are some fundamental flaws 
in a methodology that ascribes a loss of 33 DAL Ys to a newborn that dies within a few 
minutes after birth but nothing at all to an infant whose death occurs a few minutes before 
due to intra partum complications (DAL Ys and Reproductive Health 1998[c] P 3). 
Two important conceptual issues are: What is being measured in terms of burden and who 
shoulders the burden. Anand and Hanson (1996) argue that the indicator appears to be 
more reflective of "quantity" of ill-health as opposed to "burden" of ill-health as is commonly 
understood. "The burden of a condition is in direct proportion to the assistance available 
to deal with it. What is a burden to a poor women in a Third World slum is a mere passing 
inconvenience to her richer sister in New York" (DAL Ys and Reproductive Health 1998[b] 
and 1999 P 8). 
The DALY measures the amount of ill-health but it excludes socio-economic, cultural and 
environmental factors which impact on burden as well as peoples' differing abilities to cope 
with that burden (ibid). Reproductive health deals with both physiological processes and 
diseases which have unique cultural and socio-economic ramifications. 
When considering aspects of women's health such as menstruation which is a normal 
bodily function that is closely related to reproductive health, various cultural aspects come 
into play. For example, a menstruating woman in some countries cannot cook or pray or 
have intercourse with her husband. It is a real burden in terms of impeding daily life. These 
are not accounted for when using DALY methodology. 
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The theoretical underpinnings of the DAL y have the effect of discriminating against the 
socially more vulnerable sections of the population . The DALY methodology is based on 
a decision to take account of disability rather than handicap (DAL Ys and Reproductive 
ealth 1999). 
The emphasis on disability and the exclusion of other variables such as socio-economic 
status, means that women's health is not being measured adequately. The ramifications 
of certain health conditions for women are unique and should not be ignored . A specific 
example is that of obstetric fistula: permanent incontinence as a result of obstetric fistula 
seems fairly straightforward in terms of disability. However, sequelae which can include 
social isolation resulting in divorce and abandonment are less likely to follow other disabling 
conditions (DAL Ys and Reproductive Health 1998[c] P 2). "Many conditions involve 
discomfort, pain, suffering, stigma, or social or economic consequences that are not 
explicitly incorporated into the DALY" (DAL Ys and Reproductive Health 1999 P 8). Another 
example is dyspareunia, which involves relatively minor physical damage but clearly inhibits 
the individual's right to "a satisfying and safe sex life" (DAL Ys and Reproductive Health 
1998[b] P 10). 
The DALY tool has also be questioned in terms of its application of a vertical, organ and 
disease structure for the classification of diseases, namely the International Classification 
of Diseases (ICD). The result is that "diseases are grouped together in terms of related 
pathologies rather than according to epidemiological patterns, determinants and 
consequences" (DAL Ys and Reproductive Health 1998[a] P 2). This approach tends to 
neglect the inter-connectedness of diseases and conditions related to sexuality and 
reproduction. Furthermore, it has been argued that the very identification of DAL Ys "implies 
that the diseases which most people suffer are identifiable, discrete conditions which can 
be tackled one by one" (Barker and Green 1996 P 181). A consequence of this approach 
is a failure to recognise the complexity of ill-health and of interventions. In mitigation of this 
criticism of the DALY, it is argued that there have been some attempts to group related 
diseases, for example the childhood illnesses, although this may not have been adequately 
done for women's health. 
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DALY calculations are based on the Japanese model which set a standard of 82 .5 years 
for female life expectancy at birth . For males the comparable figure is 76 years . Th is 
implies a sex differential of about 6 years . In the DALY calculation the sex differential used 
is only 2.5 years ; the rationale being that the wider differential is a function of male life 
styles and behaviours and will close overtime. However, if the true biological gap is greater 
than 2.5 years , this assumption leads to an underestimation of the burden of disease for 
women relative to that of men (Anand 1996, DAL Ys and Reproductive Health 1999). On 
the other hand , if the true biological gap is less than 2,5 years, then the burden of disease 
for women will be over-estimated relative to men. 
4.7.2 TECHNICAL ISSUES WITH REGARD TO GENDER 
"Women's advocates have always pointed out that more health data are processed for men 
than for women." In addition, where there are no gender dis-aggregations, the norm is often 
the adult male (DAL Ys and Reproductive Health 1999 P 26). A problem concerning the 
1993 calculations of the global burden of reproductive ill-health relates to the databases 
which provided the foundation for the calculations themselves. The paucity of information 
on reproductive ill-health which is partly due to the difficulty of measuring gynaecological 
morbidity, inevitably leads to its neglect in the DALY calculations (DAL Ys and Reproductive 
Health 1999). 
DALY calculations are biassed towards maternal conditions and there is a relative neglect 
of other aspects of reproductive ill-health, exceptions being STDs and HIV/AIDS (ibid) . The 
conditions which are excluded are closely related to women's reproductive roles e.g. 
anaemia, osteoporosis, reproductive tract infections and sexual violence such as rape and 
sexual abuse with the associated mental health problems (DAL Ys and Reproductive 
Health 1998[b]). The focus on DAL Ys could limit the perception of women's health to 
complications and diseases related to pregnancy. Broader social and economic issues are 
ignored e.g., teenage pregnancy (Stevens 1997 P 310). Domestic violence is not included 
as a reproductive health issue despite evidence that this violence may be related to 
women's sexuality and reproduction . 
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There has been no systematic attempt to quantify the total burden of reproductive ill-health 
(DAL Ys and Reproductive Health 1998[a]) . There is a vast menu for reproductive ill-health 
including not only reproductive issues but also sexual behaviours, sexually transmitted 
diseases, diseases of reproductive organs and certain cancers. Other issues also need to 
be considered such as female genital mutilation , sexual violence and associated mental 
illness (DALY and Reproductive Health 1998[b]). Some aspects of reproductive ill-health 
neglected in the 1990 GBD study should be considered for future health research priority 
setting. For example, DALY calculations do not take into account the side-effects of 
contraception. These may be negligible in terms of mortality or disability; however, 
discontinuation may well lead to an unwanted pregnancy (DAL Ys and Reproductive Health 
1998[b]). It is suggested that sexuality and reproduction be incorporated into DALY 
calculations as a risk factor. 
The DALY does not include acute events or health conditions with a short time base. 
Physical events such as abortion or miscarriage with the associated longer lasting 
psychological burden is not valued with the use of DAL Ys. In addition , much of the overall 
burden of reproductive ill-health occurs outside the reproductive ages e.g., prolapse or 
cervical cancers (DAL Ys and Reproductive Health 1999). The health of older menopausal 
women should be included in reproductive health. 
A short-coming of the DALY, namely that of neglecting cumulative morbidity or the 
interdependence of diseases can be particularly problematic for women's health. A pre-
existing condition , such as diabetes, a tropical disease or depression can be aggravated 
by pregnancy (ibid) . Certain diseases that can affect everyone have particular 
manifestations among women, particularly during pregnancy. Examples include 
hypertension, cardiovascular disease, malaria and viral hepatitis. These can be indirect 
causes of maternal death. Even though they are not, strictly speaking, components of 
sexual or reproductive ill-health they can account for about 20% of total maternal mortality 
(DAL Ys and Reproductive Health 1998[b]). There are also some diseases that affect the 
reproductive tract that are particular manifestations of diseases that can affect anyone, 
e.g., genital schistosomiasis. The genital manifestation of the disease is thought to affect, 
at least intermittently, about 75% of women of child-bearing age in Africa who are infected 
by the parasite. Symptoms include inter-menstrual and post-coital bleeding, vulval and 
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vaginal tumours , ectopic pregnancy and infertility. In addition, some of these symptoms are 
mistaken for sexually transmitted diseases with consequent social disruption and mental 
anguish (ibid) . 
"A start on improving the current calculations could be possible with relatively limited 
investment of time or resources and even in the absence of a fundamental questioning of 
the whole approach . Information on, for example, female genital mutilation and violence 
against women should be built into the estimates as data become available" (ibid P 3) . 
The DAL Ys and Reproductive Health Reports in particular, have highlighted a number of 
technical and conceptual problems. As is the case with the general DALY critique, some 
of the technical, more practical problems can be improved with relatively simple 
modifications. However, the conceptual underpinnings with the concomitant value 
judgements and assumptions are not easily remedied (DAL Ys and Reproductive Health 
1998[b]). 
This gender critique has shown that value judgements are intrinsic to the DALY 
methodology. To reiterate: A transparent approach is needed to deal with criticisms of 
these value judgements, specifically in terms of what criteria are used as well as a 
reconsideration of the various assumptions (ibid) . 
4.8 POVERTY 
Legge (1993) incorporates a critique of the DALY within a broader criticism of the WDR. 
According to him it is not self-evident that the economic health policies of the World Bank, 
based on the utilisation of the global burden of disease exercise, are entirely consistent 
with the health needs of the poor in developing countries (Legge 1993). He maintains that 
the consideration of health issues was constrained by a concern for economic objectives. 
Legge questions the significance of the Bank ignoring the contradictions between economic 
growth and health. Legge (1993) notes that the focus of the Bank's Report is on economic 
growth with the qualification that it should help the poor. The report skirts around relations 
between inequality and health. Rapid economic growth has in many countries been 
associated with the emergence of gross inequalities and widening health differentials 
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(Legge 1993 P 17). However, in the report there is no calling to redress inequalities in the 
distribution of income and wealth. 
Legge (1993) casts aspersions on the intentions of the World Bank and its utilisation of the 
global burden of disease exercise. He maintains that the WBR ignores health and equity. 
Instead the focus is on health and poverty (UWC lecture 1996). Furthermore, the Report 
does not explicitly recognise that global interconnectedness can contribute to poor health 
in developing countries and that things like debt repayment from developing countries to 
the banking systems of the rich is not contributing to the health of the poor. Gwatkin and 
Heuveline (1997) go further than Legge and focus on the health needs of the poor. 
Criticisms of the GBD by Gwatkin and Heuveline (1997) incorporate issues such as the 
heterogeneity of the population, socio-economic factors as well as the issues of poverty 
and equity. 
The important Alma-Ata conference of 1978 drew attention to the unacceptable health 
status of hundreds of millions of poor people, especially in developing countries. Gwatkin 
and Heuveline (1997) refer to three major reports produced in the 1990s in which a concern 
about poverty and equity are important, if not central issues. 1) The 1990 report of the 
CHRC entitled, Health Research Essential Link to Equity and Development. 2) The World 
Bank's 1993 World Development Report. 3) The Initiative for Health Research and 
Development for the Poor has been established to implement the recommendations of the 
1996 Report of the WHO Ad Hoc Committee on Health Research Relating to Future 
Intervention Options (Global Health Forum) . 
They contend that the contents of these three reports profess a special concern for poverty 
but the policy recommendations are based on epidemiological analyses of population 
groups in which a majority of the people are not poor. In fact, the non-poor constitute a 
clear majority of the subject population since the poor represent no more than a third of the 
global population under any definition of poverty currently in widespread use. 
While the focus of epidemiological analysis has shifted towards the population of the world 
as a whole, most global health policy statements emphasize the importance of improving 
the health of the global poor. Gwatkin and Guillot (2000) also refer to what they perceive 
to be a lack of congruity between the emphasis of the 1990 World Health Reports dealing 
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with poverty and equity and the underlying epidemiological analysis . They maintain that the 
world 's poor cannot rely on the patterns of disease that reflect global averages for 
appropriate resource allocation (for prioritisation of health interventions and the health 
research agenda) . 
Gwatkin and Heuveline (1997) re-analysed the Murray-Lopez data for the one billion 
poorest 20% of the world population and for comparative purposes, the world 's richest 
20%. They found that while communicable diseases constituted only a minority of deaths 
in the world as a whole in 1990, they continued to cause the majority of deaths among the 
world 's poor. The relative importance of communicable and non-communicable diseases 
in the poor group is almost exactly the reverse of that appearing in the overall global figures 
(ibid P 16). 
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TABLE 4: Cause and Age Structure of Death among the Global Poorest 
and Richest 20% 
Cause of Death 
Population Group 
Disease Category Poorest 20% of the Global Population Richest 20% of 
Communicable 
diseases 
Non-communicable 
diseases 
Injuries 
Total 
~ge Category 
\ 
0-14 
15-59 
60+ 
Total 
Global Population Average 
.,._ _, 
56.1% 32.8% 
33.6% 55.7% 
10.3% 11 .5% 
100.0% 100.0% 
Age at Death 
Population Group 
Poorest 20% of the Global Population 
Global Population Average 
47.4% 29.9% 
25.7% 24.2% 
26.9% 45.9% 
100.0% 100.0% 
Source: Gwatkin and Heuveline (1997) 
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the Global 
Population 
8.4% 
84.8% 
6.8% 
100.0% 
Richest20% 
of the 
Global 
Population 
4.8% 
19.2% 
76.0% 
100.0% 
-.. 
To the extent that one wishes to set health policy priorities on the basis of burden of 
disease considerations they concluded that: 1) Among the global poorest 20%, 
communicable diseases at younger ages deserve highest priority but non-communicable 
conditions afflicting adults and the elderly cannot safely be ignored . 2) Among the global 
richest 20%, non-communicable diseases would be the primary overwhelmingly dominant 
priority. See Table 4 for the various percentages. Table 4 shows that when the health of 
the poor is analysed separately, the profile differs from the global population averages. 
The ACHR (1996) also argue that the use of the DALY which is a measure of pooled data 
across heterogeneous populations results in distorted policy making and resource 
allocation . Murray (1996[a]) suggests that by describing burden in different socio-economic 
groups there is no need to build equity into the calculation of the burden. Furthermore, on 
a global scale the calculation of GBD using DALY has demonstrated large differences in 
the burden of disease between developed and underdeveloped countries and this should 
result in more equitable health research policy. 
Sayers and Fliedner (1997) in their counter-reply state that regional heterogeneity is more 
complex than Murray and Lopez (1997[a]) imply. In order to take equity into account, 
various economic and social disparities across communities need to be considered. They 
suggest that to have a single numerical measure which must be disaggregated, is 
pointless. Paalman et al. (1998) also discusses the issue of population heterogeneity. The 
method of estimating the burden of disease fails to reveal whether a disease is 
concentrated in certain parts of the population. It is argued that most mortality and 
morbidity is concentrated in a minority of people. The identification of these individuals or 
groups is likely to lead to a different set of research priorities (Faechem 1989, Murray 
1990). 
Overall , the DALY is too focussed on the biological and genetic differe·nces between men 
and women and there is a need to examine gender inequalities and their impact on health 
outcomes. The DALY, per se, is not a good tool for estimating the differential burden for 
a given condition that is carried by the poor. As the emphasis on equity in health increases, 
the burden of disease carried by the poor as well as gender inequalities in health cannot 
be ignored. Indicators worldwide suggest that there is a growing gap between poor and 
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rich within countries and across nations and that there is an increasing feminisation of 
poverty (DAL Ys and Reproductive Health 1999). Recent statistics of the United Nations 
Development Fund show that women are still the poorest of the world 's poor representing 
70% of the 1,3 billion people who live in absolute poverty (Cape Times, August 10, 2000 
p 5) . 
4.9 USE OF THE DALY FOR RESOURCE ALLOCATION 
4.9.1 COST-EFFECTIVENESS ANALYSIS (CEA) 
Prioritisation for health research is part of the overall resource allocation for health. Cost-
effectiveness studies of health interventions is an essential component for prioritisation and 
complement a DALY analysis. In strict economic terms the size of the burden is irrelevant 
as cost-effectiveness is only concerned with efficiency. According to Musgrove (2000) , the 
emphasis in the WDR on the combination disease burden and cost-effectiveness 
constitutes its principal novelty. 
The WDR uses the US$ as common currency for measuring costs and the DALY is used 
as the unit for measuring outcomes or health effects. Different interventions can be 
compared by what it costs to achieve one additional year of healthy life. The ratio of cost 
and effect or the unit cost of a DALY is called the cost-effectiveness of the intervention; the 
lower the number the greater the value for money offered by the intervention. The aim is 
to maximize the DAL Ys averted per dollar. Assigning a monetary value facilitates decisions 
between intervention options. Priority ranking is given to those diseases which account for 
a large proportion of the burden and where there are cost effective interventions available. 
The WDR shows that large disease burdens can be controlled at relatively low costs 
(Musgrove 2000). 
Although cost-effectiveness is central for establishing intervention priorities for the WDR, 
very little information is given on the 50 health interventions chosen and evaluated for cost-
effectiveness which were obtained from another study (Paalman et al. 1998). 
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4.10 AVOIDABILITY 
Bowie et al. (1997) list five features of the DALY formula which are contentious and require 
careful consideration from an economic theory and a public health viewpoint. Besides the 
use of age-weighting , the level of discounting , the weights used for disability and the 
method of calculating life-expectancy, Bowie includes the concept of avoidability . Th is 
concept is important when using the DALY to allocate resources. 
Some components of the burden of disease in a community are impossible to do anything 
about and can be considered unavoidable. Others have been avoided but could return if 
intervention is withdrawn. Others are avoidable following the purchase of an appropriate 
health service intervention. The contribution of the unavoidable, avoided and avoidable 
components of the burden of disease need to be estimated (Investing in Health Research 
1996). It is important to take note of the avoided burden when setting priorities so as not 
to withdraw support for those interventions which are already having an impact. The issue 
of avoidability is included as part of the systematic process used by the Ad Hoc Committee 
(1994) for setting health priorities. (See Figure 7 in Chapter 2.) 
4.11 SYSTEMS ISSUES 
The use of standardised life expectancies either in measuring the global burden of disease 
or in cost-effectiveness analysis implies that health interventions alone are capable of 
achieving an increase in life expectancy to these higher levels. Other socio-economic 
determinants in health, for example, increasing female education, improving water supplies 
and sanitation and reducing accidents and violence will also need to change in order for 
life expectancy to rise to the level used in the DALY calculations. Cost-effectiveness 
analysis in the DALY framework is a restrictive analysis for resource allocation as only the 
health sector is taken into account (Anand and Hanson (ibid)). However, in order to make 
comparisons involving other sectors, monetary values would have to be assigned to the 
outcomes and cost-benefit analysis applied which would be particularly difficult for 
comparisons across countries (Musgrove 2000). 
In addition , within the medical model framework, the DALY has been criticised for failing 
to recognise links between diseases. There is also the assumption that one intervention 
can be considered largely in isolation from others (Save the Children Fund (SCF) 1993). 
Barker and Green (1996) maintain that cost-effectiveness techniques involving DAL Ys 
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result in a focus on vertical programmes. SCF (1993) suggest that the use of DAL Ys has 
no future as there is no recognition of the complexity of both ill-health and interventions. 
The use of cost-effectiveness methodology to allocate scarce resources for health 
interventions may lead to failure to build strong health systems capable of planning and 
implementation in a co-ordinated and integrated way. 
Barker and Green (1996) further contend that the health-care packages based on the 
DALY are simplistic and do not take process into account. The problem with attempting to 
determine health sector priorities by defining priority health interventions is that health-care 
planning depends on priority setting beyond those of an epidemiological nature. Barker and 
Green (ibid P 181) also maintain that the approach is in the spirit of rational comprehensive 
planning and neglects the "existing legacy of health care provision, infrastructure and power 
relations". 
Barker and Green (1966), Sayers and Fliedner (1966), Anand and Hanson (1996) and 
DAL Ys and Reproductive Health (1998[a]) all refer to the use of the medical model of care, 
with the focus on disease and treatment outcome, as being problematic for resource 
allocation health. 
4.12 CONCLUSION AND RECOMMENDATIONS 
The detailed critique of the DALY shows the very complex nature of priority setting. It 
demonstrates how the very measure that is used to guide the priority setting process 
involves assumptions and values. Furthermore, it helps elucidate the issues involved in 
priority setting ranging from the technical to the conceptual and the ethical. 
As can be ascertained from the preceding discussion, the proponents for the use of the 
DALY as a measure of burden of disease have gone some way to answer the various 
criticisms levelled at the measure. Work on the global burden of disease is on-going and 
it is constantly being updated, refined and improved. 
Composite measures together with cost-effectiveness analysis considerably aids resource 
allocation and health research prioritisation . The prioritisation process is enhanced by an 
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understanding of the limitations that are set and the consequences of the underlying 
assumptions of the health outcome measures used. 
Priorities for health research derived from poor epidemiological and incorrect cost-
effectiveness data will not be valid . It is necessary to improve economic analyses and 
'evidence-based medicine' information. The DALY methodology can be improved by 
obtaining better data and more rigorous evaluation of available data. 
Values incorporated in the DALY may be as important as technical debates (DAL Ys and 
Reproductive Health 1999). Barker and Green (1996 P 182) reject what they refer to as 
'off the peg DAL Ys' , calculated on the basis of someone else's data and incorporating their 
values. Barker and Green (1996) conclude that if DAL Ys have a future at all, they should 
be seen as indicators which must be developed locally on the basis of the judgements and 
priorities of local communities in the service of these communities. In the local context this 
will necessitate finding ways of measuring population-based values for an indigenous 
South African burden of disease study. (This relates to the health policy arena which 
cannot be ignored in the priority setting process). It is vital to incorporate community 
preferences as the criteria of equity and social justice for resource allocation are very 
important in the South African context. 
It is important to note that the DALY methodology does not have equity built in . DAL Ys are 
valued the same no matter who gains them. "Valuing DAL Ys gained by disadvantaged 
groups higher would encourage measures to improve equity" (Paalman 1998 P 29) . 
On balance, there is a case for continuing research on composite indicators for purposes 
of describing health status. However, for research prioritisation there is a need for 
additional multi-disciplinary information. 
Notwithstanding all the criticisms, it is recommended that a National Burden of Disease 
Study that estimates both mortality and non fatal outcomes for South Africa should be a 
top health research priority. In addition , the study needs to estimate the burden 
experienced by the poor. In South Africa, the Apartheid policies of the past have resulted 
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in a strong correlation between race and wealth . Thus a national burden of disease study 
needs to estimate the burden by population group. 
The DALY can be used as an adjunct tool for priority setting in the health and health 
research arena . The criticisms of the DALY such as those relating to the underlying values 
of equ ity, can also be addressed by using the DALY as a tool with in a broader, priority-
setting process such as ENHR. (This will be discussed in greater detail in Chapter 5) . The 
DALY should be part of a systematic priority-setting programme. Cognisance must be 
taken of the limitations of the DALY that have been highlighted especially those relating to 
social preferences. In South Africa where the emphasis is on the development of a new, 
equitable health system, particular note must be taken of the criticisms of the DALY that 
relate to it not being conducive to the development of an integrated health system. In 
addition , in terms of priority-setting for interventions, it is important to bear in mind that the 
measures of cost-effectiveness may not be equitable and unhelpful when adjusting for the 
mis-allocations of the past in South Africa. When setting health research priorities the focus 
should be on the needs of the poor and other vulnerable groups. In terms of gender 
inequalities, the health research needs of rural women should be prioritised . 
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CHAPTER 5 
PRIORITY SETTING FOR HEAL TH RESEARCH IN SOUTH AFRICA 
5.1 HEALTH RESEARCH PRIORITISATION IN SOUTH AFRICA 
Any process designed to set priorities .. . should not lose sight of the fundamental 
questions: 
whose voices are heard , 
whose views prevail and , thus, 
whose health interests are 
advanced? 
(RESEARCH INTO ACTION 1997) 
In South Africa there is extensive poverty and inequality and hence it is imperative that 
health research be used effectively to promote health equitably and rationally. 
5.2 HEAL TH RESEARCH EXPENDITURE IN SOUTH AFRICA 
A good start for a review of health research prioritisation in South Africa would be the 
assessment of what health research is currently funded. Health receives the next largest 
allocation of the total ANC government expenditure after education . The major focus of re-
prioritisation of expenditure in the health sector has been the expansion of access to 
primary health-care, particularly in under-served areas (Poverty and Inequality in South 
Africa 1998 P 11 ). 
Greater government health expenditure on its own (at any level of income and education) 
does not necessarily translate into better health for the population (Jamison et al. 1995). 
South Africa spends relatively more on health than most other countries yet its health 
status is poor (Sunday Times 1997). A recent WHO publication ranks South Africa number 
182 out of 191 Member States for health status, as measured by the DALE, relative to 
expenditure for 1999 (WHO 2000). South African expenditure on health is high compared 
to other middle-income countries. The World Bank describes South Africa as a Middle-
income country. Middle-income countries refer to those with per capita income of US$ 696-
US$ 8625 in 1994. In fact , South Africa with a health expenditure of 8,5% of GDP in 1990 
approaches that of Established Market Economies of 9,2% (ibid) . 
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The National Health Expenditure Review estimated in 1991/92 that only 1, 1 % of the total 
expenditure on health in South Africa was spent on research . By international standards 
this expenditure is low (Blecher and McIntyre 1995). The Third World Academy of 
Sciences recommends that 2% of Gross National Product (GNP) of developing countries 
is a necessary minimum investment in indigenous science and technology development 
with health research receiving 10% of that amount (Health Research : Essential Link to 
Equity in Development 1990). South Africa falls below this recommendation . In 1991/2 
1,04% of GDP was spent on all research with only 6,9% devoted to health (Blecher and 
McIntyre 1995). By 1995/6, 0.9% of GDP, (R484,6 billion) was spent on all research and 
14% of this was spent on health (Synthesis Report of the National Research and 
Technology Audit, DACST 1998). However, when an estimate of private sector business 
expenditure on health research is included in the calculation, this percentage is reduced 
to 11,5% (ibid), displaying a persistent shortfall. 
In addition, government funding of medical research has declined in recent years (Mbewu 
1996). Considering the scarce resources for health research it is surprising that there has 
not been an explicit process of prioritisation for health research at a national level. 
There is little information regarding what areas of research are funded in South Africa and 
accurate data on expenditure is not available. An analysis of publication titles by South 
African authors for 1994 showed that 81 % of published articles were on basic research or 
of a clinical nature (Harrison and Yach 1995). This limited method of auditing health 
research revealed a preponderance of biomedical research and dearth of public health 
research. The main explanation for the emphasis on biomedical research in South Africa 
is the apartheid-induced distortion of the health system. Priorities in health research were 
set for the minority in power at the expense of the majority. The discretionary interests of 
researchers determined research priorities (ENHR 1991 [a]) . Public health research , for 
example, with its intrinsic elements of equity were contrary to apartheid ideology. This 
experience clearly raises a further question of who prioritises for health research. 
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5.3 SETTING HEAL TH RESEARCH PRIORITIES IN SOUTH AFRICA: 
ENHR 
South Africa is undergoing major social transformation following the democratic elections 
in 1994. Health has been placed high on the political agenda by the new government and 
universal access to primary health-care has become an important goal (A National Health 
Plan for South Africa 1994 ). Research in general was given added importance in 1994 
through the establishment of a separate Ministry to manage science and technology. The 
new science policy endeavours to ensure that research will precipitate innovation and 
thereby promote social and economic development (White Paper on Science and 
Technology 1996). Applied research, is crucial to South Africa at this time (ENHR 
1991 [a]) . The necessity for health research prioritisation was acknowledged with the 
adoption of the ENHR plan . ENHR is an internationally accepted philosophical framework 
for the promotion of health and development. ENHR is a complete integrated system that 
can be used for priority setting as opposed to piecemeal research efforts. An important 
ENHR strategy is to create a dynamic process linking policy, action and research thereby 
ensuring that research funding will be promptly and efficiently applied in health 
programmes. ENHR operationalises the concepts of equity and social justice "by 
advocating a national consultative process for priority setting and identifying people and 
organisations to implement decisions reached by consensus" (National Research and 
Technology Foresight Project 1999). The Ministry of Health has recommended that ENHR 
be adopted, endorsing it as part of the reform process (White Paper for the Transformation 
of the Health System in South Africa 1997). The values of equity and development in 
ENHR are clearly important criteria for the prioritisation process in South Africa. 
Community participation has been highlighted throughout this study as an indispensable 
part of setting local priorities. "In developed countries, the task of priority setting is being 
approached by combining analysis and research evidence with public consultation and 
debate, leading to the development of guidelines or protocols on priorities" (Ham 1994). 
The ENHR process allows for community participation in the setting of national research 
priorities. 
The adoption of ENHR in South Africa began in 1991. In 1993 five representatives of 
organisations involved in community-based research attended the Geneva conference on 
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ENHR. Early in 1994 in support of ANC policy, the MRC and the alliance of progressive 
health NGOs also endorsed ENHR. 
There has been much progress in the adoption of ENHR in South Africa . In 1995 the new 
Department of Health organised a national meeting of stakeholders in health research to 
plan the implementation of ENHR. Arising from this, a National Technical Committee was 
appointed to advise the Minister of Health on how to facilitate the implementation of ENH R. 
The National Technical Committee for ENHR Report followed an initial workshop and 
together with recommendations from a second workshop, led to the Chapter on Health 
Research in the White Paper for the Transformation of the Health System in South Africa 
(ibid) . It is acknowledged in the White Paper that research has previously not been used 
to develop the health system and that there has not been a national research strategy. The 
establishment of a functional ENHR co-ordinating committee is recommended as a means 
to facilitate the implementation of this policy. 
In addition, recommendations which emerged from the combination of the committee 
report and the national workshop held early in 1996 were handed to the newly created 
office of the Chief Directorate of Health Information, Evaluation and Research (HIE&R) in 
the Department of Health. (Neufeld 1996). After further consultation with stakeholders, 
there was a consensus that prioritisation of health research was a necessary step towards 
implementing the ENHR strategy. According to the ENHR National Technical Committee 
Report (1995) , the consultative processes initiated by the committees and workshops were 
useful for motivating a general macro shift in priorities for research and identifying 
individuals and institutions to carry out research. However, the process failed to yield 
usable lists of specific research projects to be carried out at various levels of government 
(ibid). 
In September 1996 a working group was established to assist in the development of the 
criteria and processes of prioritisation. Using the approach of the Ad Hoc Committee as 
a model, the first South African ENHR conference on priority setting was held in November 
1996. There were 95 organisations identified as stakeholders in the ENHR process and 
the conference was attended by more than 160 participants representing 77 organisations 
(Proceedings of the First Essential National Health Research Congress on Priority Setting. 
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1996). These included representatives of universities, science councils , NGOs, 
international funding agencies, national and provincial health departments, government 
departments and the private sector. Local government was not represented and there was 
insufficient community representation . 
The conference on prioritisation was structured as a stepwise process over a two-day 
period . Step one involved the ranking of health problems. An assessment of health status 
and trends based on available mortality and morbidity data was presented to the 
participants. Perceptions were included in the process through extensive group 
discussions. The major health problems were identified and then ranked using a vote. The 
top ten health problems are shown in Table 5. 
Table 5: Top ten health problems identified by the 1996 Congress 
CONDITION Congress Rank 
INJURY (all causes) 1 
TB 2 
NUTRITION 3 
HIV/AIDS 4 
STDs 5 
CANCER 6 
DIARRHOEA 7 
RESP IRA TORY INFECTION 8 
MENTAL HEAL TH 9 
MALARIA 10 
Source: South African ENHR Congress 1996 
In step two, groups discussed the top ten health problems separately and attempted to 
identify broad research areas required to address these problems. The participants 
assessed why the problems persist and what could or should be researched. These broad 
research areas were categorised by discipline. In the third step, cross-cutting issues, within 
four types of research , viz. basic, clinical, social science and health systems were 
discussed. These steps were generally undertaken with limited data and relied on the 
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expert knowledge of the participants . A preliminary list of research priorities as well as 
other ENHR concerns was generated within each research type and have been 
documented in the report (ibid) . The Congress participants recommended that the list be 
considered as a basis for more substantive input from appropriate experts. 
To date, slow progress has been made with the newly established ENHR Committee in 
facilitating the finalisation of the priority research list and the constituting of an ENHR 
mechanism. Although initially ENHR was warmly embraced by the relevant stakeholders 
such as the Department of Health and the Medical Research Council , the ENHR initiative 
seems to have lost momentum. There may not yet be consensus on the way the ENHR 
mechanism works. 
The global and South African initiatives for setting health priorities have both used a 
combination of a health problem and health system approach. It would be premature to 
compare the list of research priorities identified at the South African ENHR conference with 
the global list until there has been further analysis and input. 
However, the major health challenges identified in South Africa have been contrasted with 
the global list. In order to do so, the health problems and research priorities identified 
during the South African ENHR conference were studied in conjunction with the pre-
conference submissions (ibid). Using similar groupings to those utilised in the Ad Hoc 
report and summarised in Table 6 , (Groenewald 1996) the major health challenges for 
South Africa are summarised in Table 7 (Schneider and Bradshaw, (2000, draft)). 
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Table 6: Summary of major health challenges identified by the WHO Ad Hoc Committee 
on health research relating to future intervention 
Broad health challenges Disease cluster Specific disease/problem areas 
1 The unfinished agenda Childhood infections Pneumonia 
Diarrhoeal disease 
Vaccine-preventable infections 
Malaria 
Helminth infestations 
Malnutrition 
Poor reproductive health Excess fertility/unwanted pregnancies 
Maternal and perinatal complications 
2 Evolving microbial threats Tuberculosis 
Pneumococcal disease 
Malaria 
STDs including HIV/AIDS 
3 Non-communicable diseases and Major non-communicable Psychiatric and neurological conditions 
injuries disease Cardiovascular disease 
Cancers 
Non-communicable respiratory disease 
Risk factors for non- Tobacco use 
communicable diseases Alcohol abuse 
Other (hypertension, inactivity, air 
pollution) 
Unintentional injuries Road traffic accidents 
Other unintentional injuries (burns, fires, 
poisoning) 
Risk factors for intentional injuries 
(alcohol) 
Intentional injuries Criminal homicides 
War-related injuries 
Risk factors for intentional injuries 
4 Inefficient and inequitable health Interaction between health and economy 
systems facing spiraling costs and Potential benefits of interventions in other 
lack of information to guide policy sectors 
Impact of health sector reform 
Current and projected trends in health 
status 
Demand for services at population and 
household level 
Indicators of need 
Effective indicators of health system 
performance 
Priority setting for resource allocation 
Source: Groenewald 1996 
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-Table 7: Major health challenges identified at the South African ENHR Congress 1996 
Broad challenge Problem cluster Specific problem 
1. Injuries and violence Intentional injuries Domestic and interpersonal violence 
Child and Women abuse 
Unintentional injuries Road traffic injuries 
Occupational injuries 
Poisoning (domestic and agricultural ) 
2. Evolving microbial Infectious diseases TB 
threats HIV/AIDS 
STDs 
Malaria 
Pneumonia 
Hepatitis 
3. The unfinished Malnutrition Undernourishment 
agenda Micro-nutrient deficiency 
Anaemia 
Poor child health Diarrhoea 
Measles 
Perinatal mortality 
Parasitic disease 
Breast-feeding 
Poor reproductive health Teenage pregnancy 
Unwanted pregnancy 
Maternal mortality and morbidity 
Infertility 
4. Non-communicable Major non-communicable Cancers diseases Mental health (depression , post diseases traumatic stress disorder (PTSD), 
anxiety) 
Non-communicable respiratory 
diseases (asthma, chronic obstructive 
pulmonary disorder (COPD)) 
Oral health 
Chronic diseases of lifestyle Cardiovascular diseases (stroke, IHD) 
Diabetes 
Hypertension 
Risk factors for non- Smoking 
communicable diseases Alcohol abuse 
Substance abuse 
Ageing Senility 
Arthritis 
Osteoporosis . 
Disability Physical disability 
Mental disability 
Table 7 continue/ ... 
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Broad challenge Problem cluster Specific problem 
5. Inefficient and Restructuring health care Health service financing 
inequitable health Economic analyses of policy and systems 
programmes 
Methods for evaluation and monitoring 
Criteria for allocation of resources 
Community participation in health 
service provision 
Inter-sectoral collaboration 
Health Information Systems Methods to monitor quality of services 
Poor surveillance systems 
Current and projected trends in health 
status 
6. Health and Poverty Lack of water and sanitation Development Lack/inadequate housing 
Rapid urbanisation 
Impact of inequality on health 
Environmental health Air pollution, water pollution and solid 
waste 
Occupational health Asbestosis 
Other occupational diseases 
Source: Schneider and Bradshaw (2000, draft) 
It is interesting to note that the broadly defined areas of health research prioritisation for 
South Africa and globally for developing countries are very similar. The most notable 
differences are the problems of injuries and violence which are placed in a separate 
category as a result of the high ranking accorded to these problems. Globally, injuries are 
part of the non-communicable disease group. For non-communicable diseases, ageing and 
disability are identified as specific problems in South Africa. Health-care restructuring and 
health information systems have been targeted as the main problem clusters for inefficient 
and inequitable health systems locally. Health and development is a major health challenge 
that was identified in the South African process but is not part of the global list. This 
category highlights the inter-relatedness of health to the provision of water, sanitation , 
housing, pollution and other social issues such as rapid urbanisation. It also shows the 
impact of inequality on health and reflects the development focus of the new government. 
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A fundamental difference between the South African exercise of setting research priorities 
and that of the Ad Hoc Committee was the very rapid approach used in the case of South 
Africa . The Congress was a short-term , small scale exercise. The Ad Hoc Committee used 
extensive quantification of disease burden on a global scale with projections for the year 
2020. The report of the Ad Hoc Committee was the result of a process that took two years 
with technical support provided by the WHO and the Harvard Burden of Disease Unit. In 
addition , data were generated on the relative cost-effectiveness of different interventions 
intended to reduce the burden of disease. The South African process relied less on such 
quantified information. The very rapid approach may have been compromised because of 
lack of data but it allowed the perceptions of the participants to play an important role in 
determining the top ranking of the health problems. The lack of community input also has 
a negative impact on the validity of the top ten problems identified at the Congress. In 
addition, while a broad overview of health status was presented, there was no information 
regarding the health system included at the South African conference. The challenge of 
inefficient and inequitable health systems is not dealt with adequately. In this respect, it 
would be useful to study how other developing countries have used ENHR for equitable 
development. 
Another factor which affected the validity of the rankings identified by the 1996 South 
African Congress was the lack of information on the future burden, in particular AIDS. At the 
first ENHR Congress AIDS was only ranked fourth. Subsequently however, with better 
information, AIDS has become a top priority for health research. "When disease or risk 
factors change rapidly, the present burden is not a good indicator of the priority for their 
control" (Bobadilla et al. 1994 P 173). For emerging new diseases the expected future 
burden provides better input for priority setting. 
5.4 NATIONAL RESEARCH AND TECHNOLOGY FORESIGHT 
PROJECT 
The National Research and Technology Foresight Project is an initiative by DACST "as part 
of its mandate to review and reform the Science and Technology system in South Africa" 
(National Research and Technology Foresight Project 1999 P 3). The Foresight exercise 
is a comprehensive one covering twelve major sectors. These include health, mining, 
business, agriculture, information and communication technologies. The mission statement 
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of the Foresight project on health is to prioritise research and technology strategies in the 
health sector in order to promote sustainable development in South Africa (ibid) . 
A Foresight project is inherently pro-active and reflects the belief that the future is influenced 
by today's decisions and actions. The emphasi~ in the Foresight exercise is not prediction 
but the exploration of different scenarios. Constructing these scenarios helps assess how 
well current research and technology might address future socio-economic needs, that is , 
in the next ten to twenty years . 
DA CST began the South African Foresight exercise in July 1996. The report was published 
in 1999 with the recommendation that it be repeated within five years. A distinguishing 
feature of South Africa's Foresight exercise is that it involved a very wide range of 
stakeholders with contributions from industry, labour and civil society. The methodological 
approach included, in addition to scenario analysis, a survey of opinions on research and 
technology trends as well as a strengths, weaknesses, opportunities and threats (SWOT) 
analysis. The latter is a situational analysis of the internal and external environment of the 
South African health sector. In a SWOT analysis , opportunities and threats are considered 
to originate in the external environment and strengths and weaknesses are internal, 
originating within an organisation or structure. 
The top research and development issues collated by the Foresight project are shown in 
Table 8. The development of an effective HIV/AIDS vaccine heads this list of specific 
projects for priority health research . 
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Table 8: Foresight priorities 
FORESIGHT TOP RESEARCH AND DEVELOPMENT ISSUES 
Development of an Al OS vaccine 
Development of barriers methods/microbicides for STDs/HIV 
Development of new TB drugs and a vaccine 
Development of malaria drugs and a vaccine 
Food fortification 
Injuries and violence prevention 
Health promotion targeted at the youth 
Safer fertility regulation (male and female) 
Self-management tools for chronic diseases and rehabilitation 
Novel way of developing private/public partnerships for health care 
Cost-effective on site diagnosis 
Telemedicine 
South African CDC 
Health and safety assessment techniques 
National Health Information System 
Use of smart cards 
Commercial application of indigenous knowledge 
Research into effectiveness of alternative therapies 
Tissue regeneration and gene therapy 
Rational drug design 
Source: The National Research and Technology Foresight Project: Executive Summary. Health 
The context for informed decision-making is enhanced by dialogue involving all relevant 
stakeholders. This "emphasises the human abilities of forethought, creativity, systems 
thinking, analysis and judgement " (The National Research and Technology Foresight 
Project 1999 P 3). The application of these abilities are vital for determining appropriate 
national health research priorities. 
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5.5 MEDICAL RESEARCH COUNCIL PRIORITY SETTING 
The MRC is one of eight science councils in South Africa . In 1999 the MRC received 6% of 
the Government's allocation to science. However, the international norm for a committed 
science allocation is 25% (MBewu and Mngomezulu 1999). There has been an increase in 
the MRC funding in order to address the major national health problems. DACST has 
approved a recommendation that the MR C's baseline budget be doubled over the medium-
term with funding estimated at R176, 1 million for 2000/2001 (MRC 1999-2000). 
The MRC does not have a list of research priorities nor does it report the level of funding 
allocated to different health problems. It is currently in the process of developing a more 
transparent mechanism for ascertaining, ranking and funding priorities for research . A 
consultative workshop was held in May 2000 with a small group of MRC and university 
researchers, managers and Board members together with representation from the 
Department of Health (DoH) to consider the process of priority setting for the MRC. 
At the workshop it was recommended that health research priorities for the MRC should be 
developed from the ENHR Congress, Foresight project and its own Thrust process with 
consultation within the six new National Programmes. The aim of the consultation should 
be to identify the specific types of research. (The MRC Thrust process was an earlier 
restructuring process which involved extensive consultation within 20 areas of research 
(MRC Update '98).) Furthermore there is a need for an audit of MRC research funding 
according to the specific problem area and type of research in order to ascertain detailed 
research expenditure and identify under-resourced priority research. It is suggested that the 
pro-active mechanism of 'requests for proposals' be reintroduced to address priority areas 
that are under-funded. 
5.6 THE HEAL TH SYSTEMS TRUST (HST) RESEARCH PRIORITY 
SETTING 
The HST is a non-governmental organisation that has become a recognised funder of policy 
relevant health systems research . The new health systems research agenda reflects a shift 
from policy formulation to the mechanics of implementation. This agenda has seven themes, 
each defining broad areas of research as shown in Table 9. Furthermore, it is envisaged 
that these broad research frameworks will serve to incorporate researcher initiated projects, 
addressing issues of national, provincial and district significance. 
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Table 9: HST priorities 
HST RESEARCH THEMES 
QUALITY OF CARE 
REPRODUCTIVE HEAL TH 
DECENTRALISATION 
HUMAN RESOURCES 
HEAL TH INFORMATION 
HEAL TH CARE FINANCING AND 
EXPENDITURE 
PRIVATE SECTOR 
PHARMACEUTICAL SERVICES 
Source: Health Systems Trust Research Programme 1999-2001 
Each theme has examples of research issues that could be included. Some themes have 
sub-sections, for example, HIV/AIDS/STDs are included in the Reproductive Health theme. 
These research themes are valuable for health research prioritisation as priorities are 
presented from a health system perspective. In terms of Janovsky and Cassel's model 
(1996) the focus is on the mediating organisations and the supply side rather than the 
demand side. 
5.7 THE SOUTH AFRICAN RESEARCH RESPONSE TO THE AIDS 
PANDEMIC 
AIDS is a unique disease in terms of the extent of human suffering it causes; it also has the 
potential to radically alter the future demographic profile of South Africa. Furthermore, AIDS 
will be a major problem when attempting to reduce poverty and socio-economic inequality. 
It is a priority among priorities and consequently the setting of priorities for AIDS research 
has been fast-tracked. 
The fight against AIDS is two-pronged, one arm is prevention, the other is treatment, as well 
as care and support for those infected with HIV/AIDS and others affected such as AIDS 
orphans. AIDS research must address both these areas. 
A prominent thrust for AIDS research in South Africa is finding an effective vaccine. "Never 
in history has a viral disease been controlled by drugs. That's why a vaccine is the only 
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possible way to fight HIV", Dr Walter Prozesky, SA Aids Vaccine Initiative (SAA VI) Co-
ordinator (AIDS Bulletin , December 1999). In 1999 the South African Cabinet approved over 
R220 million over seven years for the SAAVI. The Medical Research Council concluded an 
agreement with the European Union for another R11 million grant for research into 
developing a model for preparing the population for HIV/AIDS vaccination trials (ibid) . The 
SAAVI is supported by the International AIDS Vaccine Initiative (IAVI) which is investing US$ 
9.1 million in a mighty international effort to develop a preventative AIDS vaccine (MRC 
News, Sept 1999). Furthermore, the Government has ear-marked R500 million from the 
2000 Budget for combating AIDS (Health Link Bulletin 2000). 
A priority recommendation for AIDS research concerns obtaining data. Data for use in AIDS 
models for accurate projections are vital. The variables needed to model the AIDS epidemic 
include: the baseline rates of infection, behavioural risk factors, efficacy of transmission , 
incubation periods, survival times and the role of factors such as STDs which are not well 
quantified (WDR 1996). In South Africa data is needed in order to improve the application 
of the projection models of the epidemic. The required data include the timeous publication 
of national mortality data and more details concerning the antenatal clinic HIV prevalence 
figures (Dorrington 1999). 
Other AIDS research areas need to be prioritised . These include, anti-retro viral therapies , 
AZT to pregnant women, mother to child transmission, the role of breast-feeding, monitoring 
intravenous drug usage and research into microbiscides. All these are in addition to the 
South African involvement as part of a global initiative to carry out AIDS vaccine trials. 
There is the fear that the millions set aside now will continue to be squandered on AIDS 
awareness campaigns that, in the past, have not resulted in significant behavioural changes. 
In order for any initiative to be effective, the socio-economic dynamics of the AIDS epidemic 
need to be addressed (Health Link Bulletin 2000). In addition, it has been pointed out that 
it is useless allocating large sums of money when there is no capacity to implement AIDS 
prevention strategies (AIDS Bulletin 2000). Hence, it is important that the priority list includes 
research that aids the development of capacity for implementation and evaluation of the 
research priorities. 
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The political will to fight the AIDS epidemic has been shown to be an important factor in 
combating HIV/AIDS. However, public awareness and consensus are necessary to achieve 
political will in a democracy. This necessitates research on community participation in the 
battle against AIDS. 
5.8 CONCLUSIONS 
The World Bank's 1993 WDR has highlighted the fact that the health of the nation and 
sustainable economic growth are interdependent. Notwithstanding, the high political profile 
of the health sector in South Africa and despite the poverty, inequality and general scarcity 
of resources, only broad health research areas have been identified . Specific, prioritised 
health research topics have not been clearly identified. 
There has been a protracted adoption of ENHR formulated in various policy documents with 
slow follow-through. The South African ENHR Conference which took place towards the end 
of 1996 developed a list of health challenges which are similar to those identified in the 
Global Burden of Disease Study. However, specific research questions need to be identified. 
The ENHR Committee has recently been constituted and it is hoped that priority setting for 
health research will receive precedence in the ENHR process. 
There are various accordant priority lists of health research issues and health problems and 
challenges. These include: the Foresight Project, the ENHR Congress, the evolving list of the 
MRC and the HST research themes. The list of specific priorities determined by the Foresight 
exercise are important as they have a comprehensive base, namely identifying priority health 
and development research that contribute to 'wealth creation' and the 'improvement of the 
quality of life' for the people of South Africa. In addition, the goal is to help ensure that the 
country is economically competitive on a global scale in the long term. The MRC has gone 
some way to implementing the Science, Engineering and Technology Institute (SETI) 
Review's recommendation , namely that it should restructure its resources to increase 
alignment with ENHR priorities. The HST have defined the important research themes with 
corresponding examples of possible specific research issues. These latter issues have not 
been decided upon. 
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The analysis of available health research expenditure information shows that there has been 
insufficient monitoring of expenditure by health research type. There is no detailed 
information about current areas of research coupled with expenditure breakdowns. 
AIDS as a priority among priorities has received attention for deciding specific health 
research priorities. Research priority setting for AIDS has gained its own momentum outside 
the broader health research prioritisation process. This is the result of the enormity of the 
AIDS epidemic in South Africa. However, to date, the focus of the AIDS research has been 
on bio-medical research such as seeking an AIDS vaccine, with the relative neglect of 
behavioural , public health orientated AIDS research . There is no transparent, systematic 
process that is followed in order to determine the specific priorities for AIDS. The AIDS 
research and funding has not been examined taking other health research priorities into 
consideration in order to prioritise across research areas. 
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CHAPTER 6 
CONCLUSIONS, RECOMMENDATIONS AND FUTURE DIRECTIONS 
FOR HEAL TH RESEARCH PRIORITY SETTING IN SOUTH AFRICA 
6.1 CONCLUSIONS 
Health research not only leads to improved health but serves to boost socio-economic 
development. Accompanying globalisation, scientific advances and the revolution in 
information and communication technology there are growing disparities in health and 
wealth both between and within countries. In response to these global trends socio-
economic and gender equity should be central to the prioritising process for health 
research. 
In South Africa, as in the rest of the world, there is concern about the optimal allocation of 
scarce health research resources. In the past, financial support for health research was 
mainly provided for clinical and laboratory research with the emphasis on highly technical 
medical advances. The bulk of public research funding went to biomedical research while 
other important areas of health research were neglected. These neglected areas included 
health policy, health information systems, health education and promotion as well as the 
relationship between developmental policy and health . 
Overall, there is little evidence of explicit prioritisation for health research. Currently, there 
is insufficient detail concerning the exact magnitude and the manner in which health 
research funds are spent in South Africa. There is a need for greater clarity on how 
research is prioritised and funded. A full health research audit is proposed as the first step 
of the health prioritisation process in South Africa. 
While the Global Burden of Disease (GBD) is overwhelmingly in the Third World, 
investment in health research focuses mainly on the health problems of industrialised 
countries. In response to these distortions in global health research prioritisation , the 
Commission for Health Research and Development has recommended that no matter how 
poor a developing country is, the establishment and growth of an appropriate health 
research base is essential. The Commission called this base, ENHR. The ENHR strategy 
as a guiding ph ilosophy fits into the broader political climate prevailing in South Africa , 
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namely, the democratisation of the political process and a shift to social justice. The ENHR 
plan will focus South African research resources on the priority health needs of the entire 
population especially the poor. 
Prioritisation is an integral part of planning and both , developed and developing countries 
need to determine health research priorities. This can be done from a health problem or a 
systems approach. Either way, prioritisation is a complex procedure that can be tackled in 
a systematic, step-wise manner. This approach will include the consideration of factors 
such as technical feasibility, availability of various resources and capacity, as well as 
sustainability of proposed health research. 
Prioritisation is a political process that cannot be resolved by purely technical and scientific 
means but involves dialogue and debate as well as an underlying value system. 
Prioritisation relies on the less quantifiable aspects of peoples' perceptions and needs. In 
acknowledging the political nature of prioritisation, there is concomitant recognition of the 
different interest groups in society based on variables such as gender, education , religion 
and socio-economic class that in turn relate to individuals' values. Health research should 
be based on common underlying values. 
Prioritisation involves a weighting of values. Ham (1995 [b] )states that it would be useful 
to define specific values which different stakeholders consider to be important. A number 
of values can be identified that can guide decision-making and usually include: 
effectiveness, efficiency, impact, equity and prevention. Health research should involve all 
stakeholders including civil society, at all levels. To this end , partnerships should be 
developed at local, national, regional and global levels. 
There are various scientific techniques and epidemiological methods that can be used to 
manage health data and so help transform general health policy goals into specific 
objectives pursued by various stakeholders. Different approaches and priority-setting 
mechanisms will result in different priority lists. It is important to bear in mind that methods 
used to assist decisions on priorities may mask value judgements. 
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There has been extensive development of measures of health outcomes in the last decade. 
These include summary meaures such as the DFLE and the DALE as well as measures 
of the health gap such as the QAL Y and the DALY. 
An important focus in this thesis is an analysis of the contribution of the DALY to 
determining health research priorities. It is concluded that in addition to the mortality 
component, the DALY provides unique and desirable health information on non-fatal health 
outcomes that is essential for determining appropriate health research priorities. 
A review of the ongoing debate about the DALY shows that there is still some need to 
refine the DALY as a measure of burden but more importantly that it is necessary to 
incorporate local preferences into the measure and to note that a national estimate of the 
burden would not identify the needs of the poor. 
The health research priority-setting process in South Africa should be goal orientated and 
guided by the analysis of health status, burden of disease and developmental needs. 
South Africa has gone a long way in identifying national health research priorities. A 
process of consultation and a workshop of stakeholders has resulted in the identification 
of the major health challenges (see Table 7, Chapter 5). These problems have been 
ranked at a national ENHR conference. However, the top priority problems remain to be 
analysed in more depth so that a specific health research agenda can emerge. The results 
of the South African priority setting Congress should be used judiciously. It is important that 
experts in the different areas be brought together to develop the research agenda within 
each of the six delineated problem areas. It is essential that the analyses of the Ad Hoc 
Committee be brought to bear on this process so that South Africa can benefit form the 
extensive work that has already been done. 
The first four broad challenges listed in Table 71 have arisen using a health problem 
perspective and need further analysis along the lines of the five steps used by the Ad Hoc 
Committee. This requires more economic analysis and quantification than was available 
1 Injuries and violence, evolving microbiol threats, the unfinished agenda, non-communicable diseases 
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to the 1996 ENHR Conference. The information contained in the 1993 World Development 
Report and the Ad Hoc Committee Report (Investing in Health Research and Development 
1996) will provide a good basis for these analyses. In addition, the work of the Cochrane 
Collaboration Centre at the MRC to assess the effectiveness of health interventions through 
systematic review would be useful. Further analysis of available data needs to be 
undertaken to estimate the national burden of disease in South Africa and identify whether 
there are subgroups of the population suffering a disproportionate burden . 
The last two broad challenges from Table 72 have arisen from a health systems/policy 
approach and require a process similar to that suggested by Janovsky and Cassels (1996) 
to refine research priorities. This process needs to seek input from a wider range of experts 
and community than currently achieved as well as a more substantive situational analysis 
of the health-care system (Tollman 1997). 
6.2 RECOMMENDATIONS FOR RESEARCH PRIORITISATION 
A balance of priorities across these six broad challenges needs to be established . 
Identifying the priorities in health research will provide a map to guide the various 
stakeholders to determine what health research is ultimately carried out. However, 
prioritisation, considered in isolation from the other elements of ENHR, is unlikely to result 
in meaningful reform of the health research agenda. This will only be achieved if an ENHR 
Committee is established that has the capacity to drive the seven elements of ENHR. 
There are many obstacles that can undermine the implementation of ENHR (How to Boost 
the Impact of Country Mechanisms to Support ENHR 1999). The ENHR mechanism can 
become bogged down in bureaucracy, politicians may resist scrutiny of health outcomes 
and academic interests may override the primary objective of ENHR research : equity in 
health. The ENHR Committee should provide the leadership and common vision that · 
health research be aligned with the priorities of the country. It will need to have the political 
backing through clear linkages with the various ministries that will help integrate ENHR 
plans into national social development plans. Key role-players need to be mobilised and 
help define health research policy. The ENHR Committee must be flexible in its operation, 
building on what already exists and where necessary, being innovative. Part of the process 
21nefficient and inequitable health systems, health and development 
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of sustaining the ENHR mechanism is to ensure that the traditional division between 
research and action is not perpetuated . Not only is institution and individual capacity 
development through the supply of resources and technical experts, required for the 
sustainability of the ENHR mechanism, but there should be an equal focus on strategies 
that generate a demand for research. There is a need to interact with the users of research . 
Table 1 O shows a sequence of steps for research priority setting in South Africa. In Table 
1 O the first step is that the ENHR Committee become operational and co-ordinate an ENHR 
strategy. Part of this is an evaluation mechanism for auditing expenditure and research in 
the country. The important part of the recommendations shown in Table 10 for prioritisation 
is the establishment of expert panels to identify and prioritise health research in a 
systematic manner. This needs to follow the 5 steps in the case of the health system 
approach or the 3 steps in the case of the systems approach. 
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Table 10: Recommendations for setting priorities in South Africa 
STEP ACTION 
1 Establish ENHR Committee Drive the seven elements of ENHR: 
promotion and advocacy, ENHR mechanism, priority 
setting, capacity development and strengthening , 
networking, financing , evaluation 
2 Set up expert panels to identify *Health problem approach for the first 4 broad challenges: 
and prioritise specific Step 1 - calculate the burden attributable to the 
questions for each broad disease 
challenge* Step 2 - identify the reasons why the disease burden 
persists mainly because: 
Categorise by research type a) a lack of knowledge about the 
disease and its determinants; 
b) lack of tools; 
c) failure to use existing tools 
efficiently. 
Step 3 - ascertain whether the knowledge base is 
adequate to consider the development of 
new interventions. If not, more strategic 
research is necessary. 
Step 4 - will the desired intervention be cost-
effective? 
Step 5 - assess the current level of outlay for 
Research and Development on the 
particular problem 
*Health systems and policy approach for the last 2 broad 
challenges: 
Step 1 - assess the perceived importance of the 
topic, either in terms of impact on health 
status or in relation to policy objectives such 
as efficiency or equity. 
Step 2 - will proposed research advance the 
current state of knowledge 
Step 3 - research methods must yield 
information that it is useful to policy makers 
3 Establish mechanism for Review expenditure and nature of research on priorities (part 
evaluation of ENHR). 
*See Table 7 
The purpose of the above framework is not to generate a priority health research list per se but 
rather the development of a holistic, transparent system for setting health research priorities. 
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Notwithstanding the criticisms of the DALY as a measure of health outcome, it is 
recommended that the national burden of disease study proceed . In particular, the use of 
the DALY for Sub-Saharan Africa (SSA) has been criticised for its poor quality of health 
status data. However, one cannot await perfect health status data before embarking on a 
health research prioritisation exercise. Estimates of the DALY have served to pinpoint where 
there are inadequacies in the health data, to consolidate and interpret what data are 
available and often has served as the catalyst for developing innovative ways of collecting 
necessary information. Furthermore, when compared to other similar measures, it has been 
considered to be the best option as a measure of health outcome for research prioritisation . 
In addition, the DALY is still in the process of being developed and global burden of disease 
measures are being updated as better country-specific data become available. The 
originators of the DALY have also readily responded to specific criticisms. The WHO Ad 
Hoc Committee on Health research has used the DALY to estimate future health burden 
and identify health research priorities on a global scale. Above all , there is the argument by 
Black and Mclarty (1996) which is fully supported in this study, that the DALY should only 
serve to inform the decision-making process and not replace it. The DALY should be viewed 
only as a part of the entire process of setting health research priorities. 
The main recommendation for prioritising health research is that the systematic, step-wise 
approach laid out in Table 7 be applied to identify and prioritise specific health research . 
Both a health problem approach and a systems approach need to be adopted to meet the 
challenges identified. In addition a detailed audit of health research expenditure is needed. 
Two additional recommendations are that: 1) ENHR be fully implemented and 2) a complete 
national burden of disease study using DAL Ys, be undertaken. It is envisaged these 
recommendations will be utilised to develop an explicit, indigenous process of setting health 
research priorities in South Africa. 
A pilot study currently underway is reported in the second annual report of the Global Forum 
for Health Research (The 10/90 Report on Health Research 2000). This study incorporates 
the criteria and principles for the main priority-setting approaches. The Combined Approach 
proposed by the Global Forum for Health includes the ENHR approach, the Five Step 
Process of the AD Hoc Committee on Health Research and the Visual Health Information 
Profile proposed by the Advisory Committee on Health Research . These are then linked 
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with the actors and factors at various levels that determine the health status of a 
population . This is in the format of an information matrix for setting priorities in health 
research . (See Appendix 3) 
The first part is a situational analysis based on step I of the Ad Hoc Committee and a Visual 
Health Information Profile. The next part comprises all available information for steps II to 
IV of the five-step process. It is envisaged that one such matrix table be filled in for each 
major disease. The global or national priority research agenda can be defined on the basis 
of priorities for each disease and across diseases. This tool will highlight important gaps in 
the information needed to make evidence-based decisions on priorities and allow some 
decisions to be made despite limited information. (The 10/90 Report on Health Research 
2000). 
This pilot study aids the synthesis of the chapters by illustrating how the various aspects of 
priority setting can be combined . It should be closely examined as it may be helpful in 
providing practical guidelines for South Africa to utilise for health research priority setting . 
Overall it contributes to the on-going development of the process of setting priorities for 
health research . 
6.3 GENERAL RECOMMENDATIONS 
6.3.1 POLICY ANALYSIS 
Health policy analysis is referred to throughout this study. However, only health research 
priority setting has been examined in terms of the context South Africa, a developing 
country; process: how priorities are set?; content: what information is used, or what 
measurement results in what priorities?; and the actors: who? 
Ideally, what is required , is a thorough policy analysis of the entire South African health 
system using Walt's (1996) terms of context, content and process including the actors 
involved. It should be noted that it is not the money spent, but the policy, that is paramount 
for national health research priority setting. 
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6.3.2 HEALTH INFORMATION 
Good health information is a prerequisite for setting both health research priorities and a 
successful ENHR programme. Prioritisation is an information driven and iterative process . 
The setting of priorities is not a one-off exercise. Health status changes and as a result it 
is necessary to re-evaluate priorities on an ongoing basis (see Figure 6, Chapter 2). In 
terms of information, various initiatives "place South Africa in a position to make meaningful 
estimates of the national burden of disease with DAL Ys" (Bradshaw 1996). A South African 
National Health Information System (NHIS/SA) is evolving that will provide vital health status 
information on which judgements for health research priorities are based . The interim results 
of the first national Demographic and Health Survey (1999) has recently been published , 
providing useful data for priority setting. The National Audit and Foresight exercises set up 
by the Department of Arts, Culture, Science and Technology in order to establish what 
research capacity is available and what research should be prioritised will also contribute 
to this process (The National Research and Technology Foresight Project 1999). 
6.3.3 CAPACITY DEVELOPMENT 
In the long term , countries must increase the internal capacity to analyse their health 
problems and needs, set priorities, design, implement and evaluate health research . 
The priority setting process will be aided by both building on existing capacity and using 
mechanisms already in place. Existing mechanisms should be used and include those that 
assist in gauging progress towards equity in health in South Africa . Needs have been 
identified such as additional capacity for conducting cost-effectiveness analyses for various 
health research options. Many more health economists need to be trained for large scale 
economic analyses for priority setting. 
The results of the Foresight exercise are to used in formulating research capacity-building 
programmes for the higher education sector. Another area pinpointed for capacity 
development that aids health research prioritisation, is information and communication 
technologies (ICT) . 
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Health research priority setting is essentially a future-oriented exercise. The focus of 
Research and Development initiatives should be the development of ways for predicting 
future health scenarios in South Africa , as well as the solutions to these future problems. 
In addition innovative mechanisms must be developed for incorporating equity into health 
research priority setting . 
6.3.4 FUNDING/EXPENDITURE 
The National Technical Committee emphasised the role of funding and argues that fund ing 
must follow priority setting (Essential National Health Research 1995). In addition , they 
suggested that there must be a bidding process to ensure an equitable spread of projects 
across research entities. There is a need for greater clarity on current health research 
spending in South Africa , in order to implement and evaluate an ENHR strategy (Harrison 
and Yach 1995). It is important to evaluate not only lump sums of money spent on health 
research by the science councils, universities and technikons, the government and NGOs, 
but to answer questions such as whether the trend of under-funding public health research 
remains. In particular, the ENHR Congress of 1996 ranked the health problems in South 
Africa and it is important to assess whether funds have been allocated to these problems. 
It is also necessary to assess whether funding to Historically Black Universities (HBUs) has 
increased as well as the nature of research funded. The public sector needs better 
budgeting and expenditure reporting procedures that reflect the areas of research and 
specific research types. Funding allocated to and within research organisations must be dis-
aggregated according to the priority problems. There is a need for more detail on both 
expenditure and the nature of research in the private sector which includes national and 
international pharmaceutical companies. This funding information needs to be utilised by 
the ENHR partners to redirect the funding to appropriate health research . 
The National Research and Technology Foresight Project (1999) recommends that the 
funding of health research in South Africa should occur within the ENHR framework. 
Furthermore, research funding should be coordinated by the Department of Health (DoH) 
with DACST and the Department of Education (DoE). 
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"Since democratisation the South Africa government has attempted to re-prioritise 
expenditure. There is a need to focus on the impact of this expenditure on poor individuals 
and households. While public expenditure revues are a useful tool for such analysis, they 
are usually a major exercise requiring highly detailed information . South Africa must develop 
capacity to undertake more comprehensive expenditure reviews as part of the monitoring 
and evaluation of policy implementation" (Poverty and Inequality in South Africa 1998 P 8). 
6.3.5 EQUITY 
Both a health systems and a health-problem perspective has been used in the priority 
setting exercise in South Africa. It is necessary to look at the relative balance of these two 
orientations. We believe that the health-problem approach has predominated in South 
Africa as well as in the Ad Hoc report, largely as a result of the capacity to quantify it more 
readily. While a health-problem approach yields a combination of biomedical , clinical and 
health systems research , we contend that it will be slanted towards a biomedical/health 
service model as the categories being ranked are diseases, risk factors, technologies or 
health interventions. Broad developmental aspects of health or cross-cutting system issues 
will not be prioritised through such an analysis. Special attention needs to be given to 
inequalities in health as part of the process to redress social injustice. Gwatkin and 
Heuveline (1997) have shown that the burden of disease approach in analysing health-care 
needs has limitations when considering the needs of the poor. 
The "ENHR mechanism will need to monitor both movement towards equity in health 
(gauged by both health outcomes and health service outputs/processes/inputs) and 
equitable use of resources available for health research" (How to Boost the Impact of 
Country Mechanisms to Support ENHR 1999 P 4). This monitoring process will be aided by, 
for instance, the South African Health Systems Trust which publishes an annual review 
focusing on progress toward equity. 
6.3.6 COMMUNITY PARTICIPATION IN PRIORITY SETTING 
An integral part of ENHR is community involvement. How this will be applied to setting 
priorities in health research remains a challenge in South Africa. So far there has been little 
community involvement in the health research priority setting exercise. The National 
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Technical Committee stated it will be necessary to develop priorities at different levels and 
ensure that linkages occur between the various levels of decision making (Essential 
National Health Research 1995). For example, community input into health research 
prioritisation should feed into the system at the district/ local level. The sound foundation 
of a partnership between health service providers and the community would facilitate this . 
The National Research and Technology Foresight Project (1999) recommends a national 
health research priority setting process that with the participation of civil society focuses on 
co-ordinating multi-disciplinary, district and provincial priority setting processes at various 
levels. 
6.3.7 THE GLOBAL RESEARCH AGENDA 
Medical research has the potential to benefit all of mankind. Although the focus is the 
establishment of national health research priorities, it is also important to engage at the 
global level of health research prioritisation. 
Following the work of the Ad Hoc Committee the Global Forum for Health Research was 
established to continue the efforts to focus research on the needs of the poor. South 
African research priorities have a large overlap with the international research agenda. It is 
therefore important for South Africans to participate actively in this Forum. 
Developing countries need to improve data bases for health measures as well as develop 
health research prioritisation processes. "The analysis at the global level could then be 
continually enhanced by the data-based contributions from specific countries" (Essential 
National Health Research and Priority Setting 1997, P 59). The goal is one of true 
partnership, a collaborative relationship not a new dependency. South Africa must be in a 
position, i.e. have sufficient capacity to contribute to the global health research prioritisation 
process. 
In support of the renewed Health-for-All programme of the WHO, the Advisory Committee 
for Health Research has embarked on PLANET HERES" (Essential National Health 
Research and Priority Setting 1997). "Planet HERES" stands for Elanning N.e.twork for 
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tlealth &search. "PLANET HERES will promote ongoing operational health research 
planning and networking, capable of generating a global consensus among participating 
scientists in defin ing health-related research priorities for WHO" (WHO 1997 P 38) . "This 
is an integrated tool that makes use of computational logic and visualisation techniques 
among others, to inform research priority setting and resource allocation" (Essential National 
Health Research and Priority Setting 1997 P 2). In addition , it is proposed to develop 
worldwide intelligent research networks. Both planet HERES and the global intelligence 
networks will make use of evolving ICTs. This computer-supported work will be based on 
multi-disciplinary data and transnational scientific and technical cooperation (WHO 1997). 
In the new information age South Africa cannot afford to be excluded from these 
sophisticated and technologically-advanced global research prioritisation initiatives. To 
participate and obtain optimal benefits, there is a need to keep abreast of new 
developments in the field. 
6.4 RESEARCH TO IMPROVE HEALTH RESEARCH PRIORITISATION 
IN SOUTH AFRICA 
Future research should include monitoring the health research prioritisation process in 
South Africa . An important issue for all future health research concerns the quality of health 
research, i.e. the issue of research excellence for priority research. The Bangkok 
Declaration from the International Conference on Health Research for Development in 
2000, states that use be made of high quality research. In addition, there should be a strong 
ethical basis governing the design, conduct and use of research . The Declaration states that 
there should be a commitment that knowledge derived from public finds should be available 
and accessible to all. 
The collection of health information falls into the ambit of health research. The Departments 
of Home Affairs and Health should improve the quality of birth and death registration as the 
basis of health status data for the National Health Information System. There should be a 
focus on collecting data on morbidity and disability. 
For a situational analysis at the start of a priority setting exercise, there is a need for an 
audit of expenditure as well as the type of research currently underway in South Africa. In 
addition, comparative studies on health research priority setting in developed countries as 
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well as developing countries especially those using an ENHR approach , will benefit the 
process in South Africa . 
The inclusion of the community in research prioritisation is a vital component of the process. 
The various means of including people at grassroots level in the exercise of setting health 
research priorities needs to be explored. 
There has been no overall, systematic health policy analysis applied in this study. A policy 
analysis of the entire health system in South Africa will greatly assist the implementation 
of priority health research programmes once these are established. This includes analysis 
on how health research prioritisation fits into the health reform process in South Africa. 
The discussion of the South African ENHR Prioritisation Congress included details of what 
priorities emerged through this particular process in South Africa. Future research should 
include a more detailed analysis the health research priorities established at the first ENHR 
priority setting congress. 
In terms of the application of international experience being used in South Africa , 
developing countries such as Mexico, Mozambique, Thailand and the Philippines which 
have adopted an ENHR strategy can serve as case studies to ascertain how health 
research priorities are determined within the ENHR program in different countries. 
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APPENDICES 
Appendix 1: The DALY formula 
Appendix 2: The Heal Y formula 
Appendix 3: The Combined Approach : a practical framework for setting priorities in health 
research 
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APPENDIX 1 
The DALY formula 
The duration of time lost due to premature mortality is calculated using standard expected 
years of life lost, where model life-table West with an expectation of life at birth os 82 .5 for 
females and 80 for males has been used. Time lived at different ages has been valued 
using an exponential function of the form CxePx. Streams of time have been discounted 
at 3%. A continuous discounting function of the form e -r<x-a ) has been used where r is the 
discount rate and a is the age of onset.h Disability is divided into six classes, with each 
class having a severity weight between O and 1. Time lived in each class is multiplied by 
the disability weight to make it comparable with the years lost due to premature mortality. 
A general formula for the number of DAL Ys lost by one individual can be developed: 
x= a+l f DCxe-Pxe-r<x-a)dx 
x= a 
The solution of the definite integral from the age of onset a to a+L is the duration of disability 
or time lost due to premature mortality provides the DALY formula for an individual : 
- e 2 [e-<.B+r )( L)(1+ (/J+ r)(L+ a))- (1+(/J+r)a)] [ 
DC -pa l 
(/J + r) 
where Dis disability weight (or 1 for premature mortality), ris the discount rate, C is the age-
weighting correcting constant, pis the parameter from the age-weighting function, a is the 
age of onset, and L is the duration of disability or time lost due to premature mortality. This 
formula can be conveniently written in a spreadsheet cell to facilitate calculation of DAL Ys. 
In the specific form used for calculating DAL Ys, requals 0.03, P equals 0.04 and C equals 
0.16243. 
Source: Murray (1994) 
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APPENDIX 2 
Variables for Healthy Life-Years (Heal Y) Estimation 
Sign 
Incidence rate per 1000 population per year Per 1000 per year 
Ao Average age at onset Years 
Af Average age at death Years 
E(Ao) Expectation of life at age of onset Years 
A(Af) Expectation of life at age of death Years 
CFR Case fatality ratio: proportion of those developing 
the disease who die from the disease 0.00 - 1.00 
CDR Case disability ratio: proportion of those 
developing the disease who have disability from 
the disease 0.00 - 1.00 
De Extent of disability (from none to complete 
disability equivalent to death) 0.00 - 1.00 
Dt Average duration of disability for those disabled 
by the disease; a composite of temporary and 
permanent disability based on the proportion of 
cases in each category Years 
HeaLY Healthy life years lost per 1000 population per 
year: 
I x {[ CFR x {E(Ao)- [Af- Ao]}]+ [CDR x Dex Dt]} Heal Ys per 1000 
peryear 
Source: Hyder et al. (1998) 
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